<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58565</article-id><article-id pub-id-type="doi">10.7554/eLife.58565</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in <italic>Drosophila</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-186496"><name><surname>Atilano</surname><given-names>Magda L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3819-2023</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-207667"><name><surname>Grönke</surname><given-names>Sebastian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1539-5346</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192198"><name><surname>Niccoli</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225550"><name><surname>Kempthorne</surname><given-names>Liam</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204803"><name><surname>Hahn</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225548"><name><surname>Morón-Oset</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225549"><name><surname>Hendrich</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192200"><name><surname>Dyson</surname><given-names>Miranda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192201"><name><surname>Adams</surname><given-names>Mirjam Lisette</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192199"><name><surname>Hull</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225551"><name><surname>Salcher-Konrad</surname><given-names>Marie-Therese</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225552"><name><surname>Monaghan</surname><given-names>Amy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225553"><name><surname>Bictash</surname><given-names>Magda</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192202"><name><surname>Glaria</surname><given-names>Idoia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4556-489X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-146149"><name><surname>Isaacs</surname><given-names>Adrian M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6820-5534</contrib-id><email>a.isaacs@ucl.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-202970"><name><surname>Partridge</surname><given-names>Linda</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9615-0094</contrib-id><email>Linda.Partridge@age.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Genetics, Evolution and Environment, Institute of Healthy Ageing</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>UK Dementia Research Institute at UCL</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution>Max Planck Institute for Biology of Ageing</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Department of Neurodegenerative Disease, UCL Institute of Neurology</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution>Alzheimer's Research United Kingdom UCL Drug Discovery Institute, University College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ramaswami</surname><given-names>Mani</given-names></name><role>Reviewing Editor</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Senior Editor</role><aff><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution><country>India</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>19</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e58565</elocation-id><history><date date-type="received" iso-8601-date="2020-05-04"><day>04</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-03-09"><day>09</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Atilano et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Atilano et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58565-v2.pdf"/><abstract><p>G4C2 repeat expansions within the <italic>C9orf72</italic> gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The repeats undergo repeat-associated non-ATG translation to generate toxic dipeptide repeat proteins. Here, we show that insulin/IGF signalling is reduced in fly models of <italic>C9orf72</italic> repeat expansion using RNA sequencing of adult brain. We further demonstrate that activation of insulin/IGF signalling can mitigate multiple neurodegenerative phenotypes in flies expressing either expanded G4C2 repeats or the toxic dipeptide repeat protein poly-GR. Levels of poly-GR are reduced when components of the insulin/IGF signalling pathway are genetically activated in the diseased flies, suggesting a mechanism of rescue. Modulating insulin signalling in mammalian cells also lowers poly-GR levels. Remarkably, systemic injection of insulin improves the survival of flies expressing G4C2 repeats. Overall, our data suggest that modulation of insulin/IGF signalling could be an effective therapeutic approach against <italic>C9orf72</italic> ALS/FTD.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hexanucleotide repeats</kwd><kwd>C9orf72</kwd><kwd>insulin signalling</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002283</institution-id><institution>Alzheimer’s Research UK</institution></institution-wrap></funding-source><award-id>ARUK-PG2016A-6</award-id><principal-award-recipient><name><surname>Isaacs</surname><given-names>Adrian M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Partridge</surname><given-names>Linda</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><award-id>Open-access funding</award-id><principal-award-recipient><name><surname>Partridge</surname><given-names>Linda</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>648716 - C9ND</award-id><principal-award-recipient><name><surname>Isaacs</surname><given-names>Adrian M</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>UK Dementia Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Isaacs</surname><given-names>Adrian M</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Partridge</surname><given-names>Linda</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000143</institution-id><institution>Alzheimer Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Partridge</surname><given-names>Linda</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002283</institution-id><institution>Alzheimer’s Research UK</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Partridge</surname><given-names>Linda</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Modulation of insulin signalling could be an effective therapeutic approach against hexanucleotide repeat expansion related to c9ALS/FTD neurodegenerative diseases.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal neurodegenerative diseases. The most common genetic cause is a hexanucleotide G4C2 repeat expansion in the first intron of the <italic>C9orf72</italic> gene (<xref ref-type="bibr" rid="bib18">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Renton et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Gijselinck et al., 2012</xref>). Possible mechanisms for the expansion-related neurodegeneration include (i) haploinsufficiency of the <italic>C9orf72</italic> gene; (ii) transcription of the repeats in the sense and antisense direction with accumulation of RNA foci that sequester RNA binding proteins; (iii) production of toxic dipeptide-repeat proteins (DPRs) through repeat-associated non-AUG (RAN) translation (<xref ref-type="bibr" rid="bib22">Gijselinck et al., 2012</xref>; <xref ref-type="bibr" rid="bib5">Balendra and Isaacs, 2018</xref>; <xref ref-type="bibr" rid="bib69">Zu et al., 2018</xref>).</p><p>From the five DPRs produced (poly-GA, poly-GR, poly-GP, poly-PA, and poly-PR), the arginine-containing dipeptides poly-GR and poly-PR are highly toxic in cell lines, cultured neurons, <italic>Drosophila</italic>, and mice (<xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>; <xref ref-type="bibr" rid="bib62">Wen et al., 2014</xref>; <xref ref-type="bibr" rid="bib67">Zhang et al., 2018b</xref>; <xref ref-type="bibr" rid="bib68">Zhang et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Moens et al., 2019</xref>). Several mechanisms contribute to DPR-induced toxicity, including impaired translation, nucleolar stress, DNA damage, impaired nucleocytoplasmic transport, and altered stress granule dynamics (<xref ref-type="bibr" rid="bib32">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Kanekura et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib37">Lopez-Gonzalez et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Boeynaems et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Zhang et al., 2018a</xref>; <xref ref-type="bibr" rid="bib45">Moens et al., 2019</xref>).</p><p>Insulin/insulin-like growth factor (IGF) signals through a highly conserved pathway that regulates a multitude of processes such as protein synthesis, cell growth, and cell differentiation in both vertebrates and invertebrates (<xref ref-type="bibr" rid="bib6">Barbieri et al., 2003</xref>; <xref ref-type="bibr" rid="bib15">Broughton and Partridge, 2009</xref>). In vertebrates, insulin and IGFs are subspecialized into systems with overlapping but distinct biological functions, while in invertebrates there is a single insulin-like system that has the dual function of insulin/IGF signalling.</p><p>Activation of the insulin receptor (InR)/IGF-1 receptor through binding insulin/IGF-1 triggers the recruitment of an insulin receptor substrate, which in turn activates PI3-kinase and subsequently 3-phosphoinositide-dependent protein kinase 1 (PDK1). PDK1 can regulate translation via Akt and S6K. PDK1 activates Akt, which then activates mechanistic target of rapamycin (mTOR), which phosphorylates translation initiation factor 4E-binding protein (4E-BP), subsequently releasing its inhibition of the translation initiation factor 4E (eIF4E). PDK1 can also activate translation initiation factor 4B (eIF4B) through ribosomal protein S6 kinase (S6K) phosphorylation. Consequently, translation initiation is increased, protein synthesis is up-regulated, and the proteostatic machinery is also up-regulated (<xref ref-type="bibr" rid="bib13">Brogiolo et al., 2001</xref>; <xref ref-type="bibr" rid="bib63">Wullschleger et al., 2006</xref>; <xref ref-type="bibr" rid="bib56">Sonenberg and Hinnebusch, 2009</xref>; <xref ref-type="bibr" rid="bib41">Martina et al., 2012</xref>; <xref ref-type="bibr" rid="bib42">Minard et al., 2016</xref>).</p><p>IGF-1 is an important neurotrophin for the maintenance and survival of motor neurons, and in vivo studies in mouse models of SOD1-ALS have suggested that IGF-1 and IGF-2 have therapeutic efficacy (<xref ref-type="bibr" rid="bib30">Kaspar et al., 2003</xref>; <xref ref-type="bibr" rid="bib1">Allodi et al., 2016</xref>). However, the connection between insulin/IGF signalling and C9ALS/FTD is not yet clear.</p><p>Here, we present evidence that expression of (G4C2)36 in adult <italic>Drosophila</italic> neurons leads to a decrease in the levels of the insulin receptor ligands <italic>dilp</italic>2, <italic>dilp</italic>3, and <italic>dilp</italic>5. Furthermore, over-expression of an active form of the single fly insulin/IGF receptor InR in neurons, or insulin treatment, partially rescued the toxicity associated with poly-GR expression in <italic>C9orf72</italic> repeat fly models. Increased insulin/IGF signalling lowered the level of poly-GR in both fly neurons and mammalian cells, identifying a mechanism of rescue of poly-GR toxicity. Our findings indicate that enhanced insulin/IGF signalling may provide a potential therapeutic target to ameliorate the toxic effects of the <italic>C9orf72</italic> repeat expansion.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Insulin signalling is down-regulated in flies expressing expanded <italic>C9orf72</italic> repeats</title><p>To identify disease-specific gene expression patterns associated with poly-GR, we performed RNA-seq on heads of adult flies expressing ATG-driven GR100 specifically in neurons, using the Elav-GS RU486-inducible driver. RNA-seq was performed three days after induction of GR100 expression, in order to identify early changes prior to overt neurodegeneration. These flies showed strong alterations in their transcriptome when compared with the control line. We identified 2754 genes significantly differentially regulated (adjusted p&lt;0.05) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref> and GEO: GSE151826). To gain insight into the potential function of the differentially expressed genes, we performed gene ontology (GO) enrichment analysis using TopGO on the 2754 up- and down-regulated genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Flies expressing poly-GR100 showed altered expression of genes involved in pathways previously implicated in <italic>C9orf72</italic> pathology, including translation, DNA damage and repair, proteasome, and RNA metabolism (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Interestingly, neuropeptide hormone activity was the most enriched category of down-regulated genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Among these neuropeptides, <italic>Drosophila</italic> insulin-like peptides (dilps) 2, 3, and 5 were highly down-regulated (3.7-, 9.5-, and 3.2-fold change, respectively), adjusted p value&lt;0.05 – <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. RT-PCR analysis of brains of flies expressing poly-GR confirmed the lowered expression of <italic>dilp 2</italic>, <italic>3</italic>, and 5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To test whether these <italic>dilps</italic> were also down-regulated in a GGGGCC repeat model that generates poly-GR via RAN translation, we performed RT-PCR in flies expressing (G4C2)36. Lower expression of <italic>dilps</italic> was also observed in this model, although the expression change in the <italic>dilp5</italic> gene did not reach statistical significance (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Insulin signalling is down-regulated in flies expressing <italic>C9orf72</italic> repeats.</title><p>(<bold>A</bold>) Gene ontology enrichment of genes with altered expression when GR100 was expressed in neurons. In the top graph, bars represent enrichment of up- and down-regulated genes. In the bottom graph, upper bars represent only up-regulated genes, lower bars represent only down-regulated genes. Lengths of bars represent negative log-transformed, adjusted p-values for Fisher’s exact enrichment test. Bar colour indicates log2-fold changes between GR100 and control per gene. Neuropeptide/hormone activity genes were down-regulated. (<bold>B</bold>) Quantitative RT-PCR analysis of dilp 2, 3, and 5 normalized against tubulin in fly heads expressing GR100 in neurons. Data was assessed by t-test and presented as mean ± SD, n = 3; dilp2: p=0.0004; dilp3: p&lt;0.0001, dilp5: p&lt;0.0001. Genotypes: (A) w; UAS-GR100/+; ElavGS/+ (GR100), w; +; ElavGS/+ (ctrl) and (B) w; UAS-GR100/+; ElavGS/+.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Expression of GR100 in fly neurons induces strong perturbation of the transcriptome.</title><p>(<bold>A</bold>) MA-plot of DESeq2 output indicating genes that were significantly differentially expressed (red dots), non-significantly differentially expressed (grey circles), and significantly expressed outside the 4 to −4 log-fold change limit (red triangles) in GR100 over-expression flies relative to control flies. <italic>Dilp2</italic>, <italic>3,</italic> and <italic>5</italic> are annotated (blue circles). (<bold>B</bold>) Graphs display the relative expression of all genes associated with the identified GO-term categories with altered expression. Log2-fold change of the genes in GO categories: DNA repair, proteasome complex, spliceosome complex, RISC complex, and small and large ribosomal subunits. (<bold>A and B</bold>) Genotypes: w; UAS-GR100/+; ElavGS/+ (GR100) and w; +; ElavGS/+ (ctrl).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Insulin-like peptides 2, 3, and 5 are down-regulated in flies expressing (G4C2)36.</title><p>Quantitative RT-PCR analysis of dilp 2, 3, and 5 normalized against tubulin in fly heads expressing (G4C2)36 in neurons. Blue circles show data obtained from uninduced flies, red squares data obtained from induced flies. Data was assessed by t-test and presented as mean ± SD, n = 3, *p=0.017, **p=0.008, ns p=0.0620. Genotype: w; UAS-(G4C2)36 /+; ElavGS/+.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Expression of GR100 in fly neurons does not induce loss of IPCs.</title><p>(<bold>A</bold>) Representative confocal images of dilp2 immunostaining (green) in the IPCs of adult female flies expressing neuronal GR100 (induced) or not (non-induced). (<bold>B</bold>) Quantified IPC number present in brains of non-induced and induced flies expressing GR100. No significant difference (p=0.694) was found. Data was assessed by t-test and presented as mean ± SD, n = 5. (<bold>C</bold>) Quantified dilp2 mean immunofluorescence intensities in IPCs. Flies expressing GR100 had significantly reduced dilp2 levels (Mann-Witney test, ***p&lt;0.0001). Data are presented as mean ± SD, n = 24. (<bold>D</bold>) IPC immunostaining with anti-GR (red) and anti-GFP (green) antibodies. Local expression of poly-GR repeats in IPCs using dilp3-Gal4 driver showed that the IPCs were still able to produce GR100 (red). Flies expressing GFP in IPCs were used as control. Genotypes (<bold>A</bold>), (<bold>B</bold>), and (<bold>C</bold>) w; UAS-GR100/+; ElavGS/+. (<bold>D</bold>) w; UAS-GR100 /dilp3-Gal4 and w; UAS-mcd8-GFP /dilp3-Gal4.</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig1-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Insulin pathway activity is down-regulated in flies expressing (G4C2)36.</title><p>(<bold>A</bold>) Insulin signalling pathway. Insulin binds to insulin receptor, activating insulin receptor substrates and subsequently PI3K-Akt-mTOR pathway. SF1670 is a PTEN inhibitor and MK2206 is a pan-Akt inhibitor. (<bold>B</bold>) Western blot analysis of the phosphorylated and non-phosphorylated 4E-BP1. Flies expressing (G4C2)36 had a significantly decreased ratio of phosphorylated 4E-BP1 to the non-phosphorylated form compared with flies expressing both (G4C2)36 and InR<sup>Active</sup> (*p=0.03, unpaired t-test). Data are presented as mean ± SD, n = 3. Genotype (<bold>B</bold>) w; UAS-(G4C2)36/+; ElavGS/+ and w; UAS-(G4C2)36 /UAS-InR<sup>Active</sup>; ElavGS/+.</p><p><supplementary-material id="fig1s4sdata1"><label>Figure 1—figure supplement 4—source data 1.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig1-figsupp4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig1-figsupp4-v2.tif"/></fig></fig-group><p>Dilps 2, 3, and 5 are neuropeptides secreted by insulin-producing cells (IPCs) in the <italic>Drosophila</italic> brain (<xref ref-type="bibr" rid="bib13">Brogiolo et al., 2001</xref>; <xref ref-type="bibr" rid="bib26">Ikeya et al., 2002</xref>). To investigate whether reduced expression of <italic>dilps</italic> was simply due to the death of IPCs, we imaged brains of flies expressing poly-GR in all neurons. Dilp2 immunostaining showed no alteration in the number of IPCs (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A and B</xref>). However, consistent with our RNA-seq data, Dilp2 protein levels were reduced in IPCs expressing poly-GR (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). In addition, expression of poly-GR specifically in IPCs using the dilp3-Gal4 driver was not sufficient to induce neuronal cell death (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>). Reduction of <italic>dilp2</italic>, <italic>dilp3,</italic> and <italic>dilp5</italic> expression in GR100 flies was therefore not due to loss of IPCs.</p><p><italic>Dilps</italic> signal via a single insulin/IGF receptor (InR), through which they regulate the main signalling pathways that modulate 4E-BP1 phosphorylation (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>), a well-described read-out of insulin signalling in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib7">Bhandari et al., 2001</xref>; <xref ref-type="bibr" rid="bib61">Wang et al., 2003</xref>; <xref ref-type="bibr" rid="bib9">Blancquaert et al., 2010</xref>). To assess insulin/IGF pathway activity, we measured the phosphorylation state of 4E-BP1 in (G4C2)36 flies, and found that they had significantly decreased ratio of phosphorylated 4E-BP1 to the non-phosphorylated form, indicative of reduced insulin signalling (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4B</xref>). Co-expressing a constitutively active insulin receptor (InR<sup>Active</sup>) significantly increased this ratio, indicating a rescue of insulin/IGF signalling immediately downstream of the dilps (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4B</xref>). Taken together, these data indicate a reduction in insulin/IGF pathway activity in flies expressing either G4C2 repeats or poly-GR as a result of a reduction in expression of the <italic>dilps.</italic></p></sec><sec id="s2-2"><title>Activation of insulin signalling reduces G4C2 repeat toxicity in vivo</title><p>We next asked whether restoring insulin signalling in neurons could ameliorate G4C2 repeat toxicity. To assess this, we monitored the survival of flies co-expressing (G4C2)36 and InR<sup>Active</sup>, specifically in neurons, and found that their lifespan was significantly extended (p&lt;0.001) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In contrast, reducing insulin signalling through the expression of dominant-negative InR (<italic>InR<sup>DN</sup>)</italic> significantly reduced lifespan (p=0.027) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Activating insulin signalling in neurons reduced lifespan of wild-type flies (InR<sup>Active</sup>p&lt;0.0001), as previously reported (<xref ref-type="bibr" rid="bib27">Ismail et al., 2015</xref>), whilst its reduction led to increased lifespan (p=0.035) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), again as previously reported (<xref ref-type="bibr" rid="bib4">Augustin et al., 2018</xref>). These observations indicate that increasing insulin/IGF signalling specifically suppresses <italic>C9orf72</italic> repeat toxicity.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Activation of insulin signalling reduces G4C2 repeat toxicity in vivo.</title><p>(<bold>A</bold>) Lifespan of flies (n = 150) expressing (G4C2)36 or co-expressing InR constructs (InR<sup>Active</sup>, InR<sup>DN</sup>) in neurons. Lifespan was significantly extended in (G4C2)36 disease flies co-expressing InR<sup>Active</sup> compared with (G4C2)36 expressing flies (***p=2.8×10<sup>−21</sup> – log-rank test) and decreased when co-expressed with InR<sup>DN</sup> (*p=0.027). (<bold>B</bold>) Lifespan of wild-type flies (n = 150) expressing InR<sup>Active</sup> or InR<sup>DN</sup> in neurons. Lifespan was significantly reduced in flies expressing InR<sup>Active</sup> compared with control flies (***p=2.64×10<sup>−6</sup> – log-rank test) and increased in flies expressing InR<sup>DN</sup> (**p=0.0035). (<bold>C</bold>) Total activity of flies expressing (G4C2)36 in neurons was significantly reduced compared with uninduced control flies (***p=0.0003). (G4C2)36 flies co-expressing InR<sup>Active</sup> showed increased activity (*p=0.018) compared with flies expressing (G4C2)36 alone (two-away ANOVA followed by Holm-Sidak’s comparison test). Data are presented as mean with SD (n = 30 per genotype). (<bold>D</bold>) Flies expressing (G4C2)36 alone had significantly increased levels of p53 compared with flies expressing InR<sup>active</sup> (**p=0.0014, t-test). Data are presented as mean ±95% confidence intervals, n = 3. Genotypes (<bold>A</bold>) w; UAS-(G4C2)36/+; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>Active</sup>; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>DN</sup>; ElavGS/+. (<bold>B</bold>) w; ElavGS/+, w; +/UAS-InR<sup>Active</sup>; ElavGS/+, w; +/UAS-InR<sup>DN</sup>; ElavGS/+. (<bold>C and D</bold>) w; UAS-(G4C2)36/+; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>Active</sup>; ElavGS/+.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig2-data1-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig2-data2-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Expression of InR construct does not affect fly feeding or ElavGS expression system.</title><p>(<bold>A</bold>) There were no significant differences in food intake between flies expressing (G4C2 alone or co-expressing InR constructs, or between flies induced or uninduced with RU486, one-way ANOVA, followed by Tukey’s multiple comparisons test). Data is presented as mean with standard errors of the mean. (<bold>B</bold>) Dot blot analysis of (G4C2)36 transcript levels in flies ubiquitously expressing (G4C2)36 repeats alone or co-expressing InR<sup>Active</sup> and InR<sup>DN</sup> transgenes showed no significant differences across the genotypes (one-way ANOVA, followed by Dunnett’s multiple comparisons test). (<bold>C</bold>) GFP expression levels in UAS-GFP; ElavGS flies co-expressing InR<sup>Active</sup> or InR<sup>DN</sup> determined by western blot analysis. There were no significant differences (p=0.4) in GFP levels between genotypes (one-way ANOVA, followed by Tukey’s multiple comparisons test). Data is presented as mean with ±95% confidence intervals, n = 3. (<bold>D</bold>) Expression of (G4C2)36 in neurons increased day sleep of flies (***p&lt;0.0001, two-away ANOVA followed by Holm-Sidak’s comparison test), while this was abolished when (G4C2)36 was co-expressed with InR<sup>Active</sup> (ns; p=0.87). Data are mean ± SD (n = 32 per genotype). (<bold>E</bold>) Expression of (G4C2)36 in neurons increased night sleep of flies (**p=0.0007, two-away ANOVA followed by Holm-Sidak’s comparison test), while co-expression of InR<sup>Active</sup> abolished this phenotype (ns; p=0.81). Data are mean ± SD (n = 32 per genotype). Genotype (<bold>A</bold>) w; UAS-(G4C2)36/+; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>Active</sup>; ElavGS/+ and w; UAS-(G4C2)36 /UAS-InR<sup>DN</sup>; ElavGS/+. (<bold>B</bold>) w; da-GS, UAS-(G4C2)36/+, w; da-GS, UAS-(G4C2)36/UAS-InR<sup>Active</sup> and w; da-GS, UAS-(G4C2)36/UAS-InR<sup>DN</sup>. (<bold>C</bold>) w; UAS-GFP/+; ElavGS/+, w; UAS-GFP/UAS-InR<sup>Active</sup>; ElavGS/+ and w; UAS-GFP/UAS-InR<sup>DN</sup>; ElavGS/+. (<bold>D and E</bold>) w; UAS-(G4C2)36/+; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>Active</sup>; ElavGS/+.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Source data associated to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata3"><label>Figure 2—figure supplement 1—source data 3.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata4"><label>Figure 2—figure supplement 1—source data 4.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig2-figsupp1-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Induction of the neuron-specific driver requires flies to ingest RU486. To exclude the possibility that the rescue effect was a consequence of decreased fly feeding, and therefore reduced induction of the (G4C2)36 transgene, we measured food intake. There was no significant difference between the amount ingested across the different experimental groups (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). To rule out the possibility that expression of either InR<sup>Active</sup> or InR<sup>DN</sup> had a direct effect on the transcription of the G4C2 transgene, we measured the transcript repeat levels by RNA dot blot analysis in flies ubiquitously expressing the two constructs. Neither expression of InR<sup>Active</sup> or InR<sup>DN</sup> altered the G4C2 transcript levels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). To further investigate whether expression of InR<sup>Active</sup> or InR<sup>DN</sup> indirectly affected the inducible protein expression system, we measured levels of GFP driven by the Elav-GS RU486-inducible driver and found that they were unaltered in neuronal cells expressing InR<sup>Active</sup> or InR<sup>DN</sup> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Activation of insulin/IGF signalling therefore ameliorated <italic>C9orf72</italic> repeat toxicity, rather than simply reducing expression of the (G4C2)36 transgene.</p><p>To confirm that increasing insulin signalling could also ameliorate a second, distinct (G4C2)36-induced neuronal phenotype, we recorded motor activity and day sleep using a <italic>Drosophila</italic> activity monitor system. Flies expressing (G4C2)36 in adult neurons exhibited decreased locomotor activity (p=0.0003) and extended sleep periods during the day and night (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>), and these phenotypes were abolished by expression of InR<sup>Active</sup> (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>).</p><p>We next determined whether activation of insulin/IGF signalling also rescued a molecular signature of (G4C2)36 toxicity. Increased levels of p53 have been observed in <italic>C9orf72</italic> patient iPSC-neurons and fly models, and have been suggested to be a downstream marker of repeat-induced toxicity (<xref ref-type="bibr" rid="bib37">Lopez-Gonzalez et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Lopez-Gonzalez et al., 2019</xref>). We therefore tested if co-expression of InR<sup>active</sup> in (G4C2)36 flies was associated with decreased levels of p53 and found that it led to a significant reduction (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), whereas no difference was observed in uninduced flies (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These results show that increased insulin/IGF signalling can ameliorate multiple read-outs of G4C2 repeat-induced toxicity.</p></sec><sec id="s2-3"><title>Activation of insulin/IGF signalling reduces poly-GR toxicity in vivo via InR/PI3K/Akt</title><p>As toxicity in the (G4C2)36 flies is mediated by poly-GR (<xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>), and increased p53 has been suggested to be driven by poly-GR (<xref ref-type="bibr" rid="bib37">Lopez-Gonzalez et al., 2016</xref><xref ref-type="bibr" rid="bib38">Lopez-Gonzalez et al., 2019</xref>), we next assessed whether increased insulin/IGF signalling could specifically rescue poly-GR toxicity.</p><p>We took advantage of the rough eye phenotype and degeneration of eye tissue caused by expression of 36 poly-GR repeats (GR36) in the <italic>Drosophila</italic> eye (<xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>). To examine whether this pathology could be ameliorated by increased insulin/IGF signalling, we co-expressed GR36 with either InR<sup>Active</sup> or InR<sup>DN</sup> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). As previously reported (<xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>), ectopic expression of GR36 resulted in a mild rough eye and decreased eye size (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Co-expression of GR36 with InR<sup>Active</sup> increased the size and decreased the roughness of the eyes, whereas co-expression with InR<sup>DN</sup> exacerbated the rough eye phenotype and further decreased eye size (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Although insulin/IGF signalling also influenced eye cell growth in flies not expressing the dipeptide repeats (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), the effect in diseased flies was much larger (p&lt;0.0001, two-way ANOVA), indicating a specific additional interaction of insulin signalling with <italic>C9orf72</italic> repeat-induced toxicity. Expression of dilp2 had no effect (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), likely because of a negative feedback system that acts to coordinate Dilp expression levels in the central nervous system (<xref ref-type="bibr" rid="bib23">Grönke et al., 2010</xref>). To better understand how insulin/IGF signalling rescued the toxic effects of poly-GR, we interrogated the effect of downstream effectors of insulin signalling. We co-expressed GR36 with activated PI3K or Akt, which function downstream of the InR, and found that over-expression of either partially rescued the eye size of GR36 flies (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Together, these observations show that increased insulin/IGF signalling through the InR/PI3K/Akt pathway can rescue neurotoxicity associated with poly-GR expression.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Activation of insulin signalling reduces poly-GR toxicity via InR/PI3K/Akt.</title><p>(<bold>A</bold>) Stereomicroscopy images of representative 2-day-old adult <italic>Drosophila</italic> eyes expressing InR<sup>Active</sup> or InR<sup>DN</sup> using the GMR-GAL4 driver (bottom panel) or co-expressing both GR<sub>36</sub> and InR constructs (top panel). (<bold>B</bold>) Eye size of flies (n = 10 per genotype) normalized to the mean of the control eye size. Expression of InR<sup>Active</sup> in a wild-type background with GMR driver caused eye overgrowth, while InR<sup>DN</sup> decreased eye size (p&lt;0.001). Co-expression of the GR<sub>36</sub> with InR<sup>DN</sup> greatly decreased eye size (***p&lt;0.0001), while with InR<sup>Active</sup> substantially increased it (two-way ANOVA followed by Holm-Sidak’s multiple comparison test). Two-way ANOVA showed a significant interaction between InR genotype and expression of the repeats (p&lt;0.0001). Data is presented as mean ± 95% confidence intervals. (<bold>C</bold>) Eye size (n = 20) of 2-day-old adult <italic>Drosophila</italic> eyes expressing dilp2, PI3K<sup>CA</sup>, or Akt<sup>CA</sup> using the GMR-GAL4 driver. Co-expression of PI3K<sup>CA</sup> or Akt<sup>CA</sup> with GR<sub>36</sub> repeats yielded a partial rescue of the size of the eye (***p&lt;0.0001 and *p=0.036 respectively, two-way ANOVA, followed by Holm-Sidak’s multiple comparison test). Data are presented as mean ± SD. Genotypes: (<bold>A and B</bold>) w; GMR-Gal4/+, w; GMR-GAL4/UAS-InR<sup>Active</sup>, w; GMR-GAL4/UAS-InR<sup>DN</sup>, w; GMR-Gal4, UAS-GR<sub>36</sub>/+, w; GMR-Gal4, UAS-GR<sub>36</sub>/UAS-InR<sup>Active</sup>, w; GMR-Gal4, UAS-GR<sub>36</sub>/UAS-InR<sup>DN</sup>. (<bold>C</bold>) w; GMR-Gal4, UAS-GR<sub>36</sub>/+, w; GMR-Gal4, UAS-GR<sub>36</sub>/+;UAS-dilp2/+, w/PI3K<sup>CA</sup>; GMR-Gal4, UAS-GR<sub>36</sub>/+, w; GMR-Gal4, UAS-GR<sub>36</sub>/Akt<sup>CA</sup>, w; GMR-Gal4/+, w; GMR-Gal4/+; UAS-dilp2/+, w/PI3K<sup>CA</sup>; GMR-Gal4/+, w; GMR-Gal4/Akt<sup>CA</sup>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data pertaining to <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig3-v2.tif"/></fig></sec><sec id="s2-4"><title>Activation of insulin signalling can reduce poly-GR levels in flies</title><p>We next investigated the mechanism by which increased insulin signalling reduced <italic>C9orf72</italic> repeat toxicity. We tested whether activation of insulin signalling could alter the level of poly-GR present in the heads of flies expressing (G4C2)36. Using a quantitative Meso Scale Discovery (MSD) immunoassay, we found that expression of InR<sup>Active</sup> significantly decreased poly-GR levels (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Activation of insulin signalling reduces poly-GR levels in flies.</title><p>(<bold>A</bold>) GR dipeptide levels determined by Meso Scale Discovery (MSD) immunoassay were reduced in (G4C2)36 flies expressing InR<sup>Active</sup> compared to (G4C2)36 alone flies (***p=0.0001, one-way ANOVA, followed by Tukey’s multiple comparisons test). Levels of GR were normalized to the mean GR levels of control (G4C2)36 flies. Data is presented as mean ± SD, n = 8. (<bold>B</bold>) Expression of poly-GR determined by MSD immunoassay was also reduced in flies expressing both GR100 and InR<sup>Active</sup> compared to flies expressing GR100 alone (**p=0.0025, one-way ANOVA followed by Tukey’s multiple comparison test). Co-expression of InR<sup>DN</sup> slightly reduced poly-GR levels (*p=0.044). Levels of GR were normalized to the mean GR levels of control (G4C2)36. Data are presented as mean ± SD, n = 5. (<bold>C</bold>) Lifespan was significantly extended in flies (expressing ATG driven GR100 with over-expression of InR<sup>Active</sup> compared to flies only expressing GR100; ***p=1.62×10<sup>−11</sup> – log rank test). Genotypes (<bold>A</bold>) w; UAS-(G4C2)36/+; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>Active</sup>; ElavGS/+, w; UAS-(G4C2)36/UAS-InR<sup>DN</sup>; ElavGS/+. (<bold>B</bold>, <bold>C</bold>) w; UAS-GR100/+; ElavGS/+, w; UAS-GR100/UAS-InR<sup>Active</sup>; ElavGS/+, w; UAS-GR100/UAS-InR<sup>DN</sup>; ElavGS/+.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data associated to <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Source data associated to <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig4-data3-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig4-v2.tif"/></fig><p>In order to investigate whether the effect of InR<sup>Active</sup> on poly-GR levels occurs at the level of RAN translation, we investigated whether InR<sup>Active</sup> could reduce poly-GR levels in GR100 expressing flies, which generate poly-GR but do not undergo RAN translation. Neuronal expression of InR<sup>Active</sup> in GR100-expressing flies reduced poly-GR levels (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), with a concomitant extension of lifespan (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), further confirming the protective effect of increased insulin signalling. This indicates that InR<sup>Active</sup> is acting downstream of RAN translation to reduce poly-GR levels, and suggests that insulin/IGF signalling activation ameliorates toxicity by decreasing poly-GR levels.</p></sec><sec id="s2-5"><title>The PI3K/Akt pathway regulates DPR levels in a mammalian cell model</title><p>In order to determine whether the insulin-PI3K/AKT signalling pathway regulates DPR levels in mammalian cells, we utilized a nanoluciferase (NLuc) reporter which contains 92 seamless G4C2 repeats, which are preceded by 120 nucleotides of the endogenous human upstream sequence and followed by NLuc, lacking a start codon, in frame with poly-GR, termed 92R-NL. Thus the NLuc signal reports on RAN translated poly-GR levels. 92R-NL was co-transfected into HEK293T cells with a control plasmid expressing an ATG-driven firefly luciferase (FLuc) as a transfection efficiency and cell number control. To modulate the insulin-PI3K/Akt pathway, cells were treated for 2 days with either the pan-Akt inhibitor MK2206 (<xref ref-type="bibr" rid="bib25">Hirai et al., 2010</xref>) or the PTEN inhibitor SF1670 (<xref ref-type="bibr" rid="bib54">Rosivatz et al., 2006</xref>); insulin leads to the phosphorylation and activation of Akt, thus inhibiting Akt negates the effects of insulin on the PI3K/Akt pathway (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). PTEN inhibition facilitates the phosphorylation and activation of Akt, thus activating the pathway (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). MK2206 increased NLuc/polyGR levels (1.77-fold ± 0.54 SD, p=0.0168) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), while SF1670 decreased NLuc/polyGR levels (0.24-fold ± 0.09 SD, p=0.041) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Therefore, consistent with our data in flies, increasing insulin signalling via Akt decreased poly-GR levels, while inhibiting the pathway increased poly-GR.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Poly-GR levels are increased by Akt inhibition and decreased by PTEN inhibition in mammalian cells.</title><p>Poly-GR levels were measured using a NLuc reporter assay following a 48 hr treatment with either 1 µM MK2206 (AKT inhibitor) or SF1670 (PTEN inhibitor). (<bold>A</bold>) MK2206 significantly increases poly-GR levels (*p=0.0168). (<bold>B</bold>) SF1670 significantly decreases poly-GR levels (*p=0.0401). Each NLuc reading was normalized to FLuc for each well and further normalized to DMSO control treatment. Data given as mean ± SD of 4 biological replicates with 3–4 technical replicates per biological replicate. Data analyzed via two-tailed, unpaired Student’s t-test on the mean of each biological repeat.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data associated to <xref ref-type="fig" rid="fig5">Figure 5A and B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58565-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig5-v2.tif"/></fig></sec><sec id="s2-6"><title>Insulin treatment increases survival of G4C2 repeat expressing flies</title><p>Finally, we tested if treatment with insulin itself could also mitigate toxicity in flies. We injected 0.03 mg/ml insulin into fly haemolymph, equivalent to blood, at the second and seventh day post-induction of (G4C2)36 expression, and determined the effect on fly survival. Insulin treatment significantly extended lifespan in three independent cohorts of flies (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>), while modestly reducing lifespan in control, uninduced flies, again indicating a beneficial effect of insulin signalling specific to C9orf72 repeat toxicity. Higher concentrations of insulin became toxic (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>), indicating there is a therapeutic window within which insulin treatment is beneficial.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Systemic injection of insulin rescues (G4C2)36 toxicity in <italic>Drosophila</italic>.</title><p>Injection of 0.03 mg/ml insulin (INS) significantly extended lifespan of flies (n = 120) expressing (G4C2)36 when compared with flies injected with PBS (**p=0.00034, log-rank test), while it slightly shortened lifespan in non-induced flies (*p=0.043). Genotype: w; UAS-(G4C2)36 /+; ElavGS/+.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Excel sheet containing source data pertaining to <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig6-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Systemic injection of insulin reduces (G4C2)36 toxicity in <italic>Drosophila</italic>.</title><p>(<bold>A</bold>) Injection of different concentrations of insulin 0.03, 0.3, and 3 mg/ml into (G4C2)36 flies haemolymph (n = 120). Injection of 3 mg/ml insulin into (G4C2)36-induced flies greatly shortened their lifespan (p&lt;0.0001, log-rank test), while 0.3 mg/ml had no significant effect (p=0.083), and 0.03 mg/ml modestly increased lifespan (p=0.038, log-rank test, PBS induced vs. 0.03 mg/ml INS induced). In uninduced (G4C2)36 flies, injection of insulin at 0.3 or 0.03 mg/ml shortened lifespan (p&lt;0.0001, log-rank test, PBS uninduced flies vs. 0.3 mg/ml INS uninduced; p=0.039, log-rank test, PBS uninduced flies vs 0.03 mg/ml INS uninduced). (<bold>B</bold>) Injection of insulin (INS) at 0.03 mg/ml significantly extended lifespan of flies (n = 80) expressing (G4C2)36 when compared with flies injected with PBS (*p=0.037, log-rank test) in induced flies, while it shortened lifespan in non-induced flies (*p=0.007). Genotype (A, B) w; UAS-(G4C2)36/+; ElavGS/+.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Excel sheet containing source data related to <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig6-figsupp1-data1-v2.xls"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Excel sheet containing source data associated to <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-58565-fig6-figsupp1-data2-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58565-fig6-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We found impairment in insulin/IGF signalling in flies expressing either G4C2 or poly-GR repeats. We showed that enhancing insulin signalling via a constitutively active insulin receptor could rescue a range of toxic phenotypes in both G4C2 and poly-GR repeat flies, by reducing poly-GR levels. This implies that altered insulin signalling is driven by poly-GR.</p><p>The insulin/IGF pathway is highly conserved between mammals and <italic>Drosophila</italic>. In <italic>Drosophila</italic>, binding of dilps to the InR results in the activation and downstream functioning of the insulin pathway. We found that activating this pathway through up-regulation of InR/PI3K/Akt mitigated the toxicity in the fly model, at least in part by decreasing poly-GR levels, while impairing the insulin receptor exacerbated the severity of the pathology. Importantly, this effect on poly-GR levels was confirmed in a mammalian cell model. Several studies have already shown that InR is widely expressed in the central nervous system and is involved in the regulation of diverse biological functions such as gene transcription, protein translation, and glucose transporter activity (<xref ref-type="bibr" rid="bib12">Boucher et al., 2014</xref>). In a recent study, Hancock and colleagues demonstrated that InR, upon activation and nuclear transportation, associates with RNA polymerase II mainly in promoter regions of genes involved in insulin-related functions including protein synthesis, lipid metabolism, and neurodegenerative diseases (<xref ref-type="bibr" rid="bib24">Hancock et al., 2019</xref>). Additionally, Minard and colleagues showed that hyperactivation of the insulin signalling pathway leads to up-regulation of the proteostatic machinery by inducing the synthesis of cytosolic chaperones (<xref ref-type="bibr" rid="bib42">Minard et al., 2016</xref>). We therefore propose that overactivation of InR may improve gene transcription and translation of proteins that are crucial to DPR clearance and neuroprotection, although we cannot rule out an additional, independent effect on RAN translation in our G4C2 models.</p><p>The insulin signalling pathway plays a crucial role in regulation of growth and metabolism in neurons (<xref ref-type="bibr" rid="bib2">Annenkov, 2009</xref>). Dysregulation of IGF-R signalling has been linked to a variety of neurodegenerative diseases such as Alzheimer’s, Parkinson, and Huntington diseases (<xref ref-type="bibr" rid="bib51">Pang et al., 2016</xref>; <xref ref-type="bibr" rid="bib3">Arnold et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Raj and Sarkar, 2019</xref>). However, the role of insulin signalling in <italic>C9orf72</italic> ALS/FTD is not yet clear. A positive correlation of incidence of ALS with early onset type 1 diabetes has been reported (<xref ref-type="bibr" rid="bib40">Mariosa et al., 2015</xref>), and insulin and IGF-1 have been reported to be decreased in the blood and cerebrospinal fluid of ALS patients (<xref ref-type="bibr" rid="bib8">Bilic et al., 2006</xref>), although the relevance of these findings to disease progression are unclear and confirmation in larger cohorts will be necessary. Interestingly, transcriptomic microarray analysis of <italic>C9orf72</italic> patient laser-capture microdissected motor neurons identified dysregulation in PI3K/Akt signalling, confirming the relevance of our findings to <italic>C9orf72</italic> patient material (<xref ref-type="bibr" rid="bib58">Stopford et al., 2017</xref>). Reduction of Pten was also reported to reduce the toxicity of <italic>C9orf72</italic> repeats expressed in a mammalian cell line (<xref ref-type="bibr" rid="bib58">Stopford et al., 2017</xref>), again consistent with the results we describe here, and the potential therapeutic benefit of modulating this pathway. It is also of interest that the process of brain ageing has been associated with a decrease in insulin signalling as well as impairment of insulin binding (<xref ref-type="bibr" rid="bib65">Zaia and Piantanelli, 1996</xref>; <xref ref-type="bibr" rid="bib21">Frölich et al., 1998</xref>), which might explain in part why ageing is a risk factor for the disease.</p><p>In recent work, <xref ref-type="bibr" rid="bib52">Raj and Sarkar, 2019</xref> also identified <italic>Drosophila</italic> InR as a potential suppressor of poly(Q)-induced neurotoxicity and degeneration. In their study InR caused reduction of poly(Q) aggregates and improvement of the cellular transcriptional machinery. Activation of insulin signalling activation may also be implicated in the promotion of mTOR-independent autophagic clearance of poly(Q) aggregates in N2a mouse neuroblastoma cells (<xref ref-type="bibr" rid="bib64">Yamamoto et al., 2006</xref>).</p><p>Interestingly, over-expression and over-activation of IGF-1R in cell tumour lines predominantly triggers activation of the RAF/MAPK and PI3K/Akt pathways, which induces proliferation and inhibits apoptosis (<xref ref-type="bibr" rid="bib59">Tracz et al., 2016</xref>). In addition, IGF-1R over-expression inhibits the pro-apoptotic p53 through Akt phosphorylation (<xref ref-type="bibr" rid="bib16">Buck and Mulvihill, 2011</xref>). In agreement with these reports, expression of active InR in our study resulted in decreased levels of p53 pro-apoptotic protein in diseased flies, which may attenuate neuronal apoptosis and disease progression. Since <italic>C9orf72</italic> repeat expansions are characterised by several altered signalling pathways (<xref ref-type="bibr" rid="bib5">Balendra and Isaacs, 2018</xref>), it is possible that increased survival of rescued flies might be a consequence of improvement of more than one molecular defect.</p><p>We found that intra-thoracic insulin administration extended survival of flies expressing G4C2 repeats. While robust, the lifespan extension was relatively modest, which might be explained by the transient nature of the insulin treatment. Insulin and IGF-1 ligands have already been tested in neurodegenerative diseases. Intrathecal administration of IGF-1 improved motor performance, delayed the onset of disease and extended survival in the SOD1<sup>G93A</sup> mouse model of ALS (<xref ref-type="bibr" rid="bib47">Nagano et al., 2005</xref>; <xref ref-type="bibr" rid="bib48">Narai et al., 2005</xref>). However, three clinical trials of subcutaneously delivered IGF-1 in ALS reported contradictory results (<xref ref-type="bibr" rid="bib33">Lai et al., 1997</xref>; <xref ref-type="bibr" rid="bib11">Borasio et al., 1998</xref>; <xref ref-type="bibr" rid="bib57">Sorenson et al., 2008</xref>). The contradictory outcome of these trials may have been due to insufficient drug delivery to the brain and spinal cord and the fact that ALS has heterogeneous genetic risk factors.</p><p>Overall, our study suggests that modulation of the insulin/IGF signalling pathway could be an effective therapeutic intervention against hexanucleotide repeat extension associated with <italic>C9orf72</italic> neurodegenerative diseases, with InR being a genetic modifier. It will be interesting in future to study the requirement for downstream effectors of insulin signalling in the toxicity rescue. Importantly, in <italic>Drosophila</italic> there is a single insulin-like system that has the dual function of insulin/IGF signalling; thus, the toxicity mechanism described in our model might be also related to IGFs. Therefore, it will be important to test whether insulin or IGF treatment can rescue survival in other <italic>C9orf72</italic> ALS/FTD vertebrate model organisms.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td valign="top">Elav-GS</td><td valign="top"><xref ref-type="bibr" rid="bib50">Osterwalder et al., 2001</xref></td><td valign="top"/><td valign="top"/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>Da-GS</td><td><xref ref-type="bibr" rid="bib60">Tricoire et al., 2009</xref></td><td/><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>GMR-GAL4</td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#9146 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_9146">BDSC_9146</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>Dilp3-GAL4</td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#52660 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_52660">BDSC_52660</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-(G4C2)36</td><td><xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref></td><td/><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-GR100</td><td><xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref></td><td/><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-InR<sup>Active</sup></td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#8263 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_8263">BDSC_8263</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-InR<sup>DN</sup></td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#8252 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_8252">BDSC_8252</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-PI3K<sup>CA</sup></td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#25908 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_25908">BDSC_25908</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-Akt<sup>CA</sup></td><td>Bloomington <italic>Drosophila</italic> Stock Center</td><td>BL#8194 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_8194">BDSC_8194</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>D. melanogaster</italic>)</td><td>UAS-mCD8::GFP</td><td><xref ref-type="bibr" rid="bib35">Lee and Luo, 1999</xref></td><td/><td/></tr><tr><td>Cell line <break/>(<italic>Homo sapiens</italic>)</td><td>HEK293T cells</td><td>UCL Drug Discovery Institute</td><td/><td>Mycoplasma negative HEK cells</td></tr><tr><td>Recombinant DNA reagent</td><td>pGL4.53[luc2/PGK] Vector</td><td>Promega</td><td>#E5011</td><td>Firefly luciferase reporter plasmid</td></tr><tr><td>Transfected construct <break/>(<italic>H. sapiens</italic>)</td><td>92 repeat G<sub>4</sub>C<sub>2</sub>nanoluciferase reporter</td><td>UCL Dementia Research Institute</td><td/><td/></tr><tr><td>Antibody</td><td>Anti-GFP (mouse, mix of two monoclonals)</td><td>Merck</td><td>Cat#11814460001 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_390913">AB_390913</ext-link></td><td>WB (1:10.000)</td></tr><tr><td>Antibody</td><td>Anti-GR <break/>(rabbit)</td><td><xref ref-type="bibr" rid="bib44">Moens et al., 2018</xref></td><td/><td>MSD <break/>Capture: 2 µg/ml <break/>Detection: 12 µg/ml</td></tr><tr><td>Antibody</td><td>Anti-GR <break/>(rat, monoclonal)</td><td><xref ref-type="bibr" rid="bib46">Mori et al., 2013</xref></td><td>5H9</td><td>IF (1:50)</td></tr><tr><td>Antibody</td><td>Anti-dilp2 <break/>(rabbit, polyclonal)</td><td><xref ref-type="bibr" rid="bib49">Okamoto et al., 2012</xref></td><td/><td>IF (1:500)</td></tr><tr><td>Antibody</td><td>Anti-non-P 4E-BP1(rabbit monoclonal)</td><td>Cell Signalling</td><td>Cat#4923: <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_659944">AB_659944</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-P 4E-BP1 (rabbit monoclonal)</td><td>Cell Signalling</td><td>Cat#2855 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_560835">AB_560835</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-p53 (mouse monoclonal)</td><td>DSHB</td><td>Dmp53-H3 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10804170">AB_10804170</ext-link></td><td>WB <break/>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-actin <break/>(mouse monoclonal)</td><td>Abcam</td><td>Cat#Ab8224 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_449644">AB_449644</ext-link></td><td>WB (1:10.0000)</td></tr><tr><td>Antibody</td><td>Anti-tubulin <break/>(mouse monoclonal)</td><td>Sigma- Aldrich</td><td>Cat#T6199 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477583">AB_477583</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-rat IgG-Alexa fluor 647 <break/>(goat polyclonal)</td><td>ThermoFisher</td><td>Cat#A21247 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141778">AB_141778</ext-link></td><td>IF (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit IgG-Alexa fluor 488 (goat polyclonal)</td><td>ThermoFisher</td><td>Cat#A32731 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2633280">AB_2633280</ext-link></td><td>IF (1:1000)</td></tr><tr><td>Antibody</td><td>HRP-conjugated anti-mouse (goat polyclonal)</td><td>Abcam</td><td>Cat#Ab6789 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_955439">AB_955439</ext-link></td><td>WB (1:10.000)</td></tr><tr><td>Antibody</td><td>HRP-conjugated anti-rabbit (goat polyclonal)</td><td>Abcam</td><td>Cat#Ab6721 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_955447">AB_955447</ext-link></td><td>WB (1:10.000)</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp2_forward</td><td valign="top"><xref ref-type="bibr" rid="bib14">Broughton et al., 2008</xref></td><td valign="top">PCR primers</td><td><named-content content-type="sequence">ATGAGCAAGCCTTTGTCCTTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp2_reverse</td><td valign="top"><xref ref-type="bibr" rid="bib14">Broughton et al., 2008</xref></td><td valign="top">PCR primers</td><td><named-content content-type="sequence">GACCACGGAGCAGTACTCCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp3_forward</td><td valign="top">This study</td><td valign="top">PCR primers</td><td><named-content content-type="sequence">AGAGAACTTTGGACCCCGTGAA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp3_reverse</td><td valign="top">This study</td><td valign="top">PCR primers</td><td><named-content content-type="sequence">TGAACCGAACTATCACTCAACAGTCT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp5_forward</td><td valign="top">This study</td><td valign="top">PCR primers</td><td><named-content content-type="sequence">GAGGCACCTTGGGCCTATTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Dilp5_reverse</td><td valign="top">This study</td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CATGTGGTGAGATTCGGAGCTA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Tubulin_forward</td><td valign="top"><xref ref-type="bibr" rid="bib45">Moens et al., 2019</xref></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TGGGCCCGTCTGGACCACAA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Tubulin_reverse</td><td valign="top"><xref ref-type="bibr" rid="bib45">Moens et al., 2019</xref></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TCGCCGTCACCGGAGTCCAT</named-content></td></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>Drosophila</italic> stocks and maintenance</title><p><italic>Drosophila</italic> stocks were maintained on SYA food (15 g/L agar, 50 g/L sugar, 100 g/L autolysed yeast, 30 ml/L nipagin [10% in ethanol], and 3 ml/L propionic acid) at 25°C in a 12 hr light/dark cycle with constant humidity. The Elav-GS stock was generously provided by Herve Tricoire (Paris Diderot University). The dilp3-Gal4 (#52660) driver and the over-expression InR constructs lines (UAS-InR<sup>DN </sup>#8252; UAS-InR<sup>Active </sup>#8263), PI3K<sup>CA</sup> and Akt<sup>CA</sup> (UAS-PI3K<sup>CA</sup> #25908; Akt<sup>CA</sup> #8194) were obtained from the Bloomington <italic>Drosophila</italic> Stock Centre. The GMR-Gal4 and UAS-(G4C2)36, UAS-GR100, and flies have been previously described in <xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>. The da-GS was kindly provided by Veronique Monnier (<xref ref-type="bibr" rid="bib60">Tricoire et al., 2009</xref>), and the UAS-mCD8::GFP was a kind donation from Dr. Luo (<xref ref-type="bibr" rid="bib35">Lee and Luo, 1999</xref>).</p></sec><sec id="s4-2"><title><italic>Drosophila</italic> lifespan assays</title><p>The parental generation of the genotype used in each lifespan assay was allowed to lay for 24 hr on grape agar plates supplemented with yeast. Eggs were placed at a standard density into bottles containing SYA medium. Adult experimental flies were allowed to emerge and mate for 2 days before being lightly anaesthetised with CO<sub>2</sub>, and females randomly allocated onto SYA containing RU486 (200 μM) at a standard density per vial (n = 15), with a minimum 150 flies per condition. Flies were tipped onto fresh food every two days and dead flies counted. Escaping flies were censored from the data.</p></sec><sec id="s4-3"><title>RNA sequencing of neuronal poly-GR100 over-expression flies</title><p>To detect differential gene expression upon adult-onset, neuron-specific over-expression of poly-GR100, flies carrying the UAS-GR100 transgene were crossed with Elav-GS driver flies. As a control, Elav-GS driver flies were crossed with wild-type flies. Experimental flies were generated as described above. Female flies were fed for three days with 200 µM RU486, and subsequently snap frozen. Total RNA was isolated from 25 fly heads using Trizol and treated with DNase. For sequencing total RNA was depleted of ribosomal RNA and libraries were generated at the Max Planck Genome Centre Cologne (Germany). This experiment was performed in triplicate. RNA sequencing was performed with an Illumina Hi-Seq2500 and 35 million single-end reads/sample and 100 bp read length at the Max-Planck Genome Centre Cologne. Raw sequence reads were quality-trimmed using Trim Galore! (v0.3.7) and aligned using Tophat2 (<xref ref-type="bibr" rid="bib31">Kim et al., 2013</xref>) (v2.0.14) against the Dm6 reference genome. Multi-mapped reads were filtered using SAMtools (<xref ref-type="bibr" rid="bib36">Li et al., 2009</xref>). Data visualization and analysis was performed using SeqMonk, and the following Bioconductor packages: Deseq2 (<xref ref-type="bibr" rid="bib39">Love et al., 2014</xref>), topGO and org.Dm.eg.db. For visualization of functional enrichment analysis results, we further used the CellPlot package. Genes were considered to be significantly differentially expressed with an adjusted p value&lt;0.05 and no cut-off for fold change was used. Unless stated otherwise, the set of expressed genes was used as background for all functional enrichment analyses involving expression data. The data have been deposited in NCBI's Gene Expression Omnibus (GEO) (<xref ref-type="bibr" rid="bib19">Edgar et al., 2002</xref>) under the accession number GSE151826.</p></sec><sec id="s4-4"><title>RT-PCR analysis</title><p>Adult female flies were induced on SYA medium containing 200 μM R4486 for 7 days before being flash-frozen in liquid nitrogen. RNA from 12 to 15 heads per replicate was extracted using TRIzol reagent (Thermo Fisher Scientific) following the manufacturer’s protocol. Approximately 1 μg of RNA per sample was treated with TURBO DNase (Thermo Fisher Scientific), followed by reverse transcription using the SuperScript II system (Invitrogen) with random hexamers (Thermo Fisher Scientific). Quantitative RT-PCR was conducted on a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems) using SYBR Green Master Mix (Applied Biosystems). Relative mRNA levels were calculated relative to alphaTub84B expression by the comparative Ct method. Primer sequences used are described in key resource table.</p></sec><sec id="s4-5"><title>Brain immunostainings</title><p>Brains from 4-day-old female flies were dissected in PBS and immediately fixed in 4% PFA in /PBS at 4°C for 2 hr and washed for 4 × 30 min in PBST (0.5% Triton X-100 in PBS). Fly brains were then blocked in PBST + 5% fetal bovine serum (FBS; Sigma #F524) for 1 hr at RT and incubated with 5H9 rat anti-poly GR (1:50) (<xref ref-type="bibr" rid="bib46">Mori et al., 2013</xref>) or rabbit anti-dilp2 (<xref ref-type="bibr" rid="bib49">Okamoto et al., 2012</xref>) in blocking buffer for 48 hr at 4°C. The tissues were washed 4× 30 min in PBST at RT and incubated with anti-rat IgG-Alexa Fluor 647 (ThermoFischer, catalog #A-21247) or anti-rabbit IgG-Alexa Fluor 488 (ThermoFischer, catalog #A-32731), diluted 1:1000 in blocking solution for 2 hr at RT, and washed 4× 30 min with PBST. The brains were then incubated 50% glycerol-PBS and mounted in Vectashield mounting medium (Vectorlabs, catalog #H-1200), and confocal stacks were taken with a 2 µm step size using a Leica SP8X confocal and a dry 20× (for whole brains) or a glycerol IMM 60× (for IPC zooms) objectives. The mean dilp2 immunofluorescence within each cluster of brain IPCs was calculated using the FIJI package (2.0.0-rc-43/1.51 p; NIH) software. Z projections (SUM projection) of image stacks were created. The mean fluorescence within a region adjacent to the IPCs served as background and was subtracted from the mean dilp2 fluorescence within the IPCs. Finally, a mean value representing each genotype/condition was calculated. Total numbers of IPCs were counted from each Z brain projection.</p></sec><sec id="s4-6"><title>Dot blot analysis</title><p>Total RNA of 25 female flies per genotype was extracted using Trizol and the Qiagen RNeasy Mini kit. For the dot blot analysis, 5 µg of RNA per sample were spotted onto a positively charged nylon membrane (GE Healthcare). The membrane was briefly washed with 10× SSC and RNA was then cross-linked to the membrane surface using a UVC 500 crosslinker (Amersham Biosciences). A (GGCCCC)<sub>5</sub> oligonucleotide probe was 5' labelled with γ[32P]-ATP using polynucleotide kinase to detect sense repeats. The membrane was prehybridized with ULTRAhyb-Oligo hybridization buffer (Thermo Fisher Scientific) for 1 hr at 42°C before adding the oligonucleotide probe. Hybridisation was carried out over night at 42°C. The membrane was washed twice for 30 min in 2× SSC/0.1% SDS and then exposed to X-ray films. After autoradiography the membrane was stripped by boiling in 0.1% SDS for 30 min. For normalization the blot was re-hybridized with a probe detecting ribosomal protein RpL32 transcripts. Dot intensities were quantified in Fiji.</p></sec><sec id="s4-7"><title>Assessment of eye phenotypes</title><p>Flies carrying UAS-InR constructs, UAS-PI3K<sup>CA</sup> and UAS-Akt<sup>CA</sup> were crossed to the GMR-GAL4; UAS-(G4C2)36 driver line. The progeny were allowed to develop and eclose at 25°C; female eyes were imaged 2 days after emergence. All eye images were obtained under the same magnification; eye area was calculated from each image using ImageJ (<xref ref-type="bibr" rid="bib55">Schneider et al., 2012</xref>).</p></sec><sec id="s4-8"><title>Activity and sleep analysis</title><p>Two-day-old mated female flies (n = 32) developed and eclosed under 12 hr:12 hr light:dark cycle conditions (12L:12D) were fed with food containing either 200 µM RU486 or ethanol vehicle for 12 days. After transferring into tubes, locomotor activity and sleep behaviour were recorded over 4 days in 12L:12D using the <italic>Drosophila</italic> Activity Monitor (DAM, TriKinetics Inc, MA) system within the experimental incubator (Percival), set at 25°C and 65% humidity. Fly activity is measured by infra-red beam crosses in the DAM tube. After 2 days of acclimatisation, data were acquired from a 24 hr period on the third day (beginning at the onset of lights-on). A custom Microsoft Excel workbook (<xref ref-type="bibr" rid="bib17">Chen et al., 2019</xref>) was used to calculate total activity counts per fly in the day and night periods, and to calculate sleep minutes during the day period (continuous periods of fly inactivity lasting 5 min or longer were classified as sleep). Flies with more than 12 hr of continuous inactivity at the end of the experiment were excluded as potentially dead.</p></sec><sec id="s4-9"><title><italic>Drosophila</italic> poly-GR MSD immunoassay</title><p>Heads from female flies (n = 15) induced on SYA medium containing 200 μM RU486 for 7 days were collected and processed as described previously to measure poly-GR levels (<xref ref-type="bibr" rid="bib44">Moens et al., 2018</xref>).</p></sec><sec id="s4-10"><title>Fly protein extraction and western blot</title><p>Heads from female flies (n = 15) induced with 200 μM RU486 for 7 days were collected and processed as previously described (<xref ref-type="bibr" rid="bib43">Mizielinska et al., 2014</xref>). Membranes were incubated overnight at 4°C with primary antibodies: mouse anti-GFP (Ab#11814460001; MilliporeSigma) (1:10.000 in TBS-T); mouse anti-actin antibody (ab8224, Abcam – 1:10.000 in TBS-T); mouse anti-tubulin (T6199, Sigma-Aldrich – 1:2000); mouse anti-p53 (dmp53-H3, DSHB – 1:200); rabbit anti-non-P 4E-BP1 (4923, Cell Signaling – 1:1000); and rabbit anti-P 4E-BP1 (2855, Cell Signaling – 1:1000). HRP-conjugated anti-mouse and anti-rabbit secondary antibodies (ab6789 and ab6721, Abcam – 1:10.000) were used for 1 hr at room temperature.</p></sec><sec id="s4-11"><title>Insulin treatment</title><p>Injections were performed twice, on the second day of repeat induction and 5 days later, by anesthetising the flies with CO<sub>2</sub>. For each experiment, adult female flies (n = 80) were injected into the thorax with 32 nl of insulin (0.03 mg/ml) in PBS (pH 7.5) using a nanoinjector (Nanoject III; Drummond Scientific). Injection of the same volume of PBS acted as a control. Injected flies were then maintained at 25°C and transferred to fresh vials every third day throughout the experiment. They were collected at the indicated time points and directly processed for western blot analysis.</p></sec><sec id="s4-12"><title>Food intake – CAFE assay</title><p>In the capillary feeder assay (CAFE), a single female fly was presented with liquid food using one 10 µl calibrated capillary per chamber (n = 15 per condition). Changes in liquid meniscus height were measured over 3 days at each capillary change. Feeding volume was calculated after background subtraction of measurements from control chambers without flies.</p></sec><sec id="s4-13"><title>Nanoluciferase assay of poly-GR levels</title><p>For dual-luciferase assays, mycoplasma-free HEK293T cells were used and maintained in DMEM media supplemented with 10% FBS, 4.5 g/L glucose, 110 mg/L sodium pyruvate, and 1× GlutaMAX and kept at 37°C with 5% CO<sub>2</sub>. HEK293T cells were plated at a density of 30,000 cells per well in a 96-well plate. The following day, the cells were transiently transfected with 12.5 ng of firefly luciferase expression plasmid, and 2.5 ng of RAN translated poly-GR nanoluciferase reporter plasmid (92R-NL) using Lipofectamine 2000 according to manufacturer’s instructions. One hour post-transfection, cells were treated with 1 µM of either MK2206 (Cayman Chemicals, #11593), SF1670 (Merck, # SML0684), or a DMSO control. Each experiment consists of three technical replicate wells per condition, with experiments repeated three times independently. 48 hr post-transfection both firefly and nanoluciferase signals were measured using the Nano-Glo Dual Luciferase Assay according to manufacturer’s instructions, on the FLUOstar Omega (BMG Labtech) with a threshold of 80% and a gain of 2000 for both readings. The nanoluciferase reading was normalised to the firefly luciferase reading for each well to control for variable transfection efficiencies and this normalised value was further normalized to the control DMSO treatment.</p></sec><sec id="s4-14"><title>Experimental design and statistical analysis</title><p>Statistical analyses were performed with Prism6 (GraphPad Software). Normality of data was tested using the D’Agostino-Pearson omnibus normality test. When data were normally distributed, a Student’s t-test, one-way ANOVA, or two-way ANOVA was performed followed by multiple comparison test. For all data figures, the n values can be found in the figure legends and correspond to the number of biological repeats used in the analysis. Results were presented as mean ± 95% confidence intervals unless stated otherwise. Statistical differences were considered significant at p&lt;0.05. Log-rank test on lifespan data were performed in Microsoft Excel (template available at <ext-link ext-link-type="uri" xlink:href="http://piperlab.org/resources/">http://piperlab.org/resources/</ext-link>) and data was plotted using Prism6.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was funded by Alzheimer’s Research UK (ARUK-PG2016A-6) (AMI), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (648716 – C9ND) (AMI), the UK Dementia Research Institute (AMI), which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK, the Wellcome Trust (LP), and the Max Planck Society (LP). We are grateful for the technical support provided by Mumtaz Ahmad, Giovanna Vinti, Enric Ureña, and Nikunj Gupta. Some stocks used in this study were obtained from the Bloomington Drosophila Stock Center (NIH P400D018537).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con11"><p>Methodology</p></fn><fn fn-type="con" id="con12"><p>Methodology</p></fn><fn fn-type="con" id="con13"><p>Methodology</p></fn><fn fn-type="con" id="con14"><p>Investigation</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-58565-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE151826. All data generated or analysed during this study are included in the manuscript.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Atilano</surname><given-names>ML</given-names></name><name><surname>Grönke</surname><given-names>S</given-names></name><name><surname>Hahn</surname><given-names>O</given-names></name><name><surname>Niccoli</surname><given-names>T</given-names></name><name><surname>Kempthorne</surname><given-names>L</given-names></name><name><surname>Morón-Oset</surname><given-names>J</given-names></name><name><surname>Hull</surname><given-names>A</given-names></name><name><surname>Hendrich</surname><given-names>O</given-names></name><name><surname>Dyson</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>ML</given-names></name><name><surname>Monaghan</surname><given-names>A</given-names></name><name><surname>Salcher-Konrad</surname><given-names>MT</given-names></name><name><surname>Bictash</surname><given-names>M</given-names></name><name><surname>Isaacs</surname><given-names>AM</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>mRNA profiles from heads of old female control (elavGS/+) and polyGR100 flies</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151826">GSE151826</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allodi</surname> <given-names>I</given-names></name><name><surname>Comley</surname> <given-names>L</given-names></name><name><surname>Nichterwitz</surname> <given-names>S</given-names></name><name><surname>Nizzardo</surname> <given-names>M</given-names></name><name><surname>Simone</surname> <given-names>C</given-names></name><name><surname>Benitez</surname> <given-names>JA</given-names></name><name><surname>Cao</surname> <given-names>M</given-names></name><name><surname>Corti</surname> <given-names>S</given-names></name><name><surname>Hedlund</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>25960</elocation-id><pub-id pub-id-type="doi">10.1038/srep25960</pub-id><pub-id pub-id-type="pmid">27180807</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annenkov</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis</article-title><source>Molecular Neurobiology</source><volume>40</volume><fpage>195</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/s12035-009-8081-0</pub-id><pub-id pub-id-type="pmid">19714501</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname> <given-names>SE</given-names></name><name><surname>Arvanitakis</surname> <given-names>Z</given-names></name><name><surname>Macauley-Rambach</surname> <given-names>SL</given-names></name><name><surname>Koenig</surname> <given-names>AM</given-names></name><name><surname>Wang</surname> <given-names>HY</given-names></name><name><surname>Ahima</surname> <given-names>RS</given-names></name><name><surname>Craft</surname> <given-names>S</given-names></name><name><surname>Gandy</surname> <given-names>S</given-names></name><name><surname>Buettner</surname> <given-names>C</given-names></name><name><surname>Stoeckel</surname> <given-names>LE</given-names></name><name><surname>Holtzman</surname> <given-names>DM</given-names></name><name><surname>Nathan</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Brain insulin resistance in type 2 diabetes and alzheimer disease: concepts and conundrums</article-title><source>Nature Reviews Neurology</source><volume>14</volume><fpage>168</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2017.185</pub-id><pub-id pub-id-type="pmid">29377010</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname> <given-names>H</given-names></name><name><surname>McGourty</surname> <given-names>K</given-names></name><name><surname>Allen</surname> <given-names>MJ</given-names></name><name><surname>Adcott</surname> <given-names>J</given-names></name><name><surname>Wong</surname> <given-names>CT</given-names></name><name><surname>Boucrot</surname> <given-names>E</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Impact of insulin signaling and proteasomal activity on physiological output of a neuronal circuit in aging <italic>Drosophila melanogaster</italic></article-title><source>Neurobiology of Aging</source><volume>66</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.02.027</pub-id><pub-id pub-id-type="pmid">29579685</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balendra</surname> <given-names>R</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C9orf72-mediated ALS and FTD: multiple pathways to disease</article-title><source>Nature Reviews Neurology</source><volume>14</volume><fpage>544</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1038/s41582-018-0047-2</pub-id><pub-id pub-id-type="pmid">30120348</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname> <given-names>M</given-names></name><name><surname>Bonafè</surname> <given-names>M</given-names></name><name><surname>Franceschi</surname> <given-names>C</given-names></name><name><surname>Paolisso</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans</article-title><source>American Journal of Physiology-Endocrinology and Metabolism</source><volume>285</volume><fpage>E1064</fpage><lpage>E1071</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00296.2003</pub-id><pub-id pub-id-type="pmid">14534077</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhandari</surname> <given-names>BK</given-names></name><name><surname>Feliers</surname> <given-names>D</given-names></name><name><surname>Duraisamy</surname> <given-names>S</given-names></name><name><surname>Stewart</surname> <given-names>JL</given-names></name><name><surname>Gingras</surname> <given-names>AC</given-names></name><name><surname>Abboud</surname> <given-names>HE</given-names></name><name><surname>Choudhury</surname> <given-names>GG</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name><name><surname>Kasinath</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells</article-title><source>Kidney International</source><volume>59</volume><fpage>866</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2001.059003866.x</pub-id><pub-id pub-id-type="pmid">11231341</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilic</surname> <given-names>E</given-names></name><name><surname>Bilic</surname> <given-names>E</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Kusec</surname> <given-names>V</given-names></name><name><surname>Zurak</surname> <given-names>N</given-names></name><name><surname>Delimar</surname> <given-names>D</given-names></name><name><surname>Zagar</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls</article-title><source>European Journal of Neurology</source><volume>13</volume><fpage>1340</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.2006.01503.x</pub-id><pub-id pub-id-type="pmid">17116217</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blancquaert</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Paternot</surname> <given-names>S</given-names></name><name><surname>Coulonval</surname> <given-names>K</given-names></name><name><surname>Dumont</surname> <given-names>JE</given-names></name><name><surname>Harris</surname> <given-names>TE</given-names></name><name><surname>Roger</surname> <given-names>PP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells implication in Mitogenesis and activation of CDK4</article-title><source>Molecular Endocrinology</source><volume>24</volume><fpage>1453</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1210/me.2010-0087</pub-id><pub-id pub-id-type="pmid">20484410</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Kovacs</surname> <given-names>D</given-names></name><name><surname>Konijnenberg</surname> <given-names>A</given-names></name><name><surname>Timmerman</surname> <given-names>E</given-names></name><name><surname>Volkov</surname> <given-names>A</given-names></name><name><surname>Guharoy</surname> <given-names>M</given-names></name><name><surname>De Decker</surname> <given-names>M</given-names></name><name><surname>Jaspers</surname> <given-names>T</given-names></name><name><surname>Ryan</surname> <given-names>VH</given-names></name><name><surname>Janke</surname> <given-names>AM</given-names></name><name><surname>Baatsen</surname> <given-names>P</given-names></name><name><surname>Vercruysse</surname> <given-names>T</given-names></name><name><surname>Kolaitis</surname> <given-names>RM</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Kedersha</surname> <given-names>N</given-names></name><name><surname>Anderson</surname> <given-names>P</given-names></name><name><surname>Impens</surname> <given-names>F</given-names></name><name><surname>Sobott</surname> <given-names>F</given-names></name><name><surname>Schymkowitz</surname> <given-names>J</given-names></name><name><surname>Rousseau</surname> <given-names>F</given-names></name><name><surname>Fawzi</surname> <given-names>NL</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Tompa</surname> <given-names>P</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics</article-title><source>Molecular Cell</source><volume>65</volume><fpage>1044</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.013</pub-id><pub-id pub-id-type="pmid">28306503</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borasio</surname> <given-names>GD</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Leigh</surname> <given-names>PN</given-names></name><name><surname>Emile</surname> <given-names>J</given-names></name><name><surname>Guiloff</surname> <given-names>RJ</given-names></name><name><surname>Jerusalem</surname> <given-names>F</given-names></name><name><surname>Silani</surname> <given-names>V</given-names></name><name><surname>Vos</surname> <given-names>PE</given-names></name><name><surname>Wokke</surname> <given-names>JH</given-names></name><name><surname>Dobbins</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis european ALS/IGF-I study group</article-title><source>Neurology</source><volume>51</volume><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1212/wnl.51.2.583</pub-id><pub-id pub-id-type="pmid">9710040</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname> <given-names>J</given-names></name><name><surname>Charalambous</surname> <given-names>M</given-names></name><name><surname>Zarse</surname> <given-names>K</given-names></name><name><surname>Mori</surname> <given-names>MA</given-names></name><name><surname>Kleinridders</surname> <given-names>A</given-names></name><name><surname>Ristow</surname> <given-names>M</given-names></name><name><surname>Ferguson-Smith</surname> <given-names>AC</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes</article-title><source>PNAS</source><volume>111</volume><fpage>14512</fpage><lpage>14517</lpage><pub-id pub-id-type="doi">10.1073/pnas.1415475111</pub-id><pub-id pub-id-type="pmid">25246545</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brogiolo</surname> <given-names>W</given-names></name><name><surname>Stocker</surname> <given-names>H</given-names></name><name><surname>Ikeya</surname> <given-names>T</given-names></name><name><surname>Rintelen</surname> <given-names>F</given-names></name><name><surname>Fernandez</surname> <given-names>R</given-names></name><name><surname>Hafen</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>An evolutionarily conserved function of the <italic>Drosophila</italic> insulin receptor and insulin-like peptides in growth control</article-title><source>Current Biology</source><volume>11</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00068-9</pub-id><pub-id pub-id-type="pmid">11250149</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broughton</surname> <given-names>S</given-names></name><name><surname>Alic</surname> <given-names>N</given-names></name><name><surname>Slack</surname> <given-names>C</given-names></name><name><surname>Bass</surname> <given-names>T</given-names></name><name><surname>Ikeya</surname> <given-names>T</given-names></name><name><surname>Vinti</surname> <given-names>G</given-names></name><name><surname>Tommasi</surname> <given-names>AM</given-names></name><name><surname>Driege</surname> <given-names>Y</given-names></name><name><surname>Hafen</surname> <given-names>E</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Reduction of DILP2 in <italic>Drosophila</italic> triages a metabolic phenotype from lifespan revealing redundancy and compensation among DILPs</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3721</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003721</pub-id><pub-id pub-id-type="pmid">19005568</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broughton</surname> <given-names>S</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Insulin/IGF-like signalling, the central nervous system and aging</article-title><source>Biochemical Journal</source><volume>418</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1042/BJ20082102</pub-id><pub-id pub-id-type="pmid">19159343</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname> <given-names>E</given-names></name><name><surname>Mulvihill</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Small molecule inhibitors of the IGF-1R/IR Axis for the treatment of Cancer</article-title><source>Expert Opinion on Investigational Drugs</source><volume>20</volume><fpage>605</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1517/13543784.2011.558501</pub-id><pub-id pub-id-type="pmid">21446886</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>KF</given-names></name><name><surname>Lowe</surname> <given-names>S</given-names></name><name><surname>Lamaze</surname> <given-names>A</given-names></name><name><surname>Krätschmer</surname> <given-names>P</given-names></name><name><surname>Jepson</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neurocalcin regulates nighttime sleep and arousal in <italic>Drosophila</italic></article-title><source>eLife</source><volume>8</volume><elocation-id>e38114</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38114</pub-id><pub-id pub-id-type="pmid">30865587</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Boxer</surname> <given-names>AL</given-names></name><name><surname>Baker</surname> <given-names>M</given-names></name><name><surname>Rutherford</surname> <given-names>NJ</given-names></name><name><surname>Nicholson</surname> <given-names>AM</given-names></name><name><surname>Finch</surname> <given-names>NA</given-names></name><name><surname>Flynn</surname> <given-names>H</given-names></name><name><surname>Adamson</surname> <given-names>J</given-names></name><name><surname>Kouri</surname> <given-names>N</given-names></name><name><surname>Wojtas</surname> <given-names>A</given-names></name><name><surname>Sengdy</surname> <given-names>P</given-names></name><name><surname>Hsiung</surname> <given-names>GY</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Seeley</surname> <given-names>WW</given-names></name><name><surname>Josephs</surname> <given-names>KA</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Wszolek</surname> <given-names>ZK</given-names></name><name><surname>Feldman</surname> <given-names>H</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS</article-title><source>Neuron</source><volume>72</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id><pub-id pub-id-type="pmid">21944778</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>R</given-names></name><name><surname>Domrachev</surname> <given-names>M</given-names></name><name><surname>Lash</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Gene expression omnibus: ncbi gene expression and hybridization array data repository</article-title><source>Nucleic Acids Research</source><volume>30</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id><pub-id pub-id-type="pmid">11752295</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>KH</given-names></name><name><surname>Badders</surname> <given-names>N</given-names></name><name><surname>Valentine</surname> <given-names>M</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/nature14974</pub-id><pub-id pub-id-type="pmid">26308899</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frölich</surname> <given-names>L</given-names></name><name><surname>Blum-Degen</surname> <given-names>D</given-names></name><name><surname>Bernstein</surname> <given-names>HG</given-names></name><name><surname>Engelsberger</surname> <given-names>S</given-names></name><name><surname>Humrich</surname> <given-names>J</given-names></name><name><surname>Laufer</surname> <given-names>S</given-names></name><name><surname>Muschner</surname> <given-names>D</given-names></name><name><surname>Thalheimer</surname> <given-names>A</given-names></name><name><surname>Türk</surname> <given-names>A</given-names></name><name><surname>Hoyer</surname> <given-names>S</given-names></name><name><surname>Zöchling</surname> <given-names>R</given-names></name><name><surname>Boissl</surname> <given-names>KW</given-names></name><name><surname>Jellinger</surname> <given-names>K</given-names></name><name><surname>Riederer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Brain insulin and insulin receptors in aging and sporadic alzheimer's disease</article-title><source>Journal of Neural Transmission</source><volume>105</volume><fpage>423</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1007/s007020050068</pub-id><pub-id pub-id-type="pmid">9720972</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>Van Langenhove</surname> <given-names>T</given-names></name><name><surname>van der Zee</surname> <given-names>J</given-names></name><name><surname>Sleegers</surname> <given-names>K</given-names></name><name><surname>Philtjens</surname> <given-names>S</given-names></name><name><surname>Kleinberger</surname> <given-names>G</given-names></name><name><surname>Janssens</surname> <given-names>J</given-names></name><name><surname>Bettens</surname> <given-names>K</given-names></name><name><surname>Van Cauwenberghe</surname> <given-names>C</given-names></name><name><surname>Pereson</surname> <given-names>S</given-names></name><name><surname>Engelborghs</surname> <given-names>S</given-names></name><name><surname>Sieben</surname> <given-names>A</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Vandenberghe</surname> <given-names>R</given-names></name><name><surname>Santens</surname> <given-names>P</given-names></name><name><surname>De Bleecker</surname> <given-names>J</given-names></name><name><surname>Maes</surname> <given-names>G</given-names></name><name><surname>Bäumer</surname> <given-names>V</given-names></name><name><surname>Dillen</surname> <given-names>L</given-names></name><name><surname>Joris</surname> <given-names>G</given-names></name><name><surname>Cuijt</surname> <given-names>I</given-names></name><name><surname>Corsmit</surname> <given-names>E</given-names></name><name><surname>Elinck</surname> <given-names>E</given-names></name><name><surname>Van Dongen</surname> <given-names>J</given-names></name><name><surname>Vermeulen</surname> <given-names>S</given-names></name><name><surname>Van den Broeck</surname> <given-names>M</given-names></name><name><surname>Vaerenberg</surname> <given-names>C</given-names></name><name><surname>Mattheijssens</surname> <given-names>M</given-names></name><name><surname>Peeters</surname> <given-names>K</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Cras</surname> <given-names>P</given-names></name><name><surname>Martin</surname> <given-names>J-J</given-names></name><name><surname>De Deyn</surname> <given-names>PP</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study</article-title><source>The Lancet Neurology</source><volume>11</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(11)70261-7</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grönke</surname> <given-names>S</given-names></name><name><surname>Clarke</surname> <given-names>DF</given-names></name><name><surname>Broughton</surname> <given-names>S</given-names></name><name><surname>Andrews</surname> <given-names>TD</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Molecular evolution and functional characterization of <italic>Drosophila</italic> insulin-like peptides</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1000857</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000857</pub-id><pub-id pub-id-type="pmid">20195512</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname> <given-names>ML</given-names></name><name><surname>Meyer</surname> <given-names>RC</given-names></name><name><surname>Mistry</surname> <given-names>M</given-names></name><name><surname>Khetani</surname> <given-names>RS</given-names></name><name><surname>Wagschal</surname> <given-names>A</given-names></name><name><surname>Shin</surname> <given-names>T</given-names></name><name><surname>Ho Sui</surname> <given-names>SJ</given-names></name><name><surname>Näär</surname> <given-names>AM</given-names></name><name><surname>Flanagan</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Insulin receptor associates with promoters Genome-wide and regulates gene expression</article-title><source>Cell</source><volume>177</volume><fpage>722</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.030</pub-id><pub-id pub-id-type="pmid">30955890</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>H</given-names></name><name><surname>Sootome</surname> <given-names>H</given-names></name><name><surname>Nakatsuru</surname> <given-names>Y</given-names></name><name><surname>Miyama</surname> <given-names>K</given-names></name><name><surname>Taguchi</surname> <given-names>S</given-names></name><name><surname>Tsujioka</surname> <given-names>K</given-names></name><name><surname>Ueno</surname> <given-names>Y</given-names></name><name><surname>Hatch</surname> <given-names>H</given-names></name><name><surname>Majumder</surname> <given-names>PK</given-names></name><name><surname>Pan</surname> <given-names>BS</given-names></name><name><surname>Kotani</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MK-2206, an allosteric akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</article-title><source>Molecular Cancer Therapeutics</source><volume>9</volume><fpage>1956</fpage><lpage>1967</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-09-1012</pub-id><pub-id pub-id-type="pmid">20571069</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeya</surname> <given-names>T</given-names></name><name><surname>Galic</surname> <given-names>M</given-names></name><name><surname>Belawat</surname> <given-names>P</given-names></name><name><surname>Nairz</surname> <given-names>K</given-names></name><name><surname>Hafen</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Nutrient-dependent expression of insulin-like peptides from neuroendocrine cells in the CNS contributes to growth regulation in <italic>Drosophila</italic></article-title><source>Current Biology</source><volume>12</volume><fpage>1293</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(02)01043-6</pub-id><pub-id pub-id-type="pmid">12176357</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname> <given-names>MZ</given-names></name><name><surname>Hodges</surname> <given-names>MD</given-names></name><name><surname>Boylan</surname> <given-names>M</given-names></name><name><surname>Achall</surname> <given-names>R</given-names></name><name><surname>Shirras</surname> <given-names>A</given-names></name><name><surname>Broughton</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The <italic>Drosophila</italic> insulin receptor independently modulates lifespan and locomotor senescence</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0125312</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125312</pub-id><pub-id pub-id-type="pmid">26020640</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Chai</surname> <given-names>N</given-names></name><name><surname>Yamada</surname> <given-names>SB</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Herdy</surname> <given-names>JR</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Kramer</surname> <given-names>NJ</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1226</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1038/nn.4085</pub-id><pub-id pub-id-type="pmid">26308983</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanekura</surname> <given-names>K</given-names></name><name><surname>Yagi</surname> <given-names>T</given-names></name><name><surname>Cammack</surname> <given-names>AJ</given-names></name><name><surname>Mahadevan</surname> <given-names>J</given-names></name><name><surname>Kuroda</surname> <given-names>M</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Urano</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>1803</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw052</pub-id><pub-id pub-id-type="pmid">26931465</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaspar</surname> <given-names>BK</given-names></name><name><surname>Lladó</surname> <given-names>J</given-names></name><name><surname>Sherkat</surname> <given-names>N</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model</article-title><source>Science</source><volume>301</volume><fpage>839</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1126/science.1086137</pub-id><pub-id pub-id-type="pmid">12907804</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Pertea</surname> <given-names>G</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Kelley</surname> <given-names>R</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biology</source><volume>14</volume><elocation-id>R36</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>I</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Theodoropoulos</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells</article-title><source>Science</source><volume>345</volume><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1126/science.1254917</pub-id><pub-id pub-id-type="pmid">25081482</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>EC</given-names></name><name><surname>Felice</surname> <given-names>KJ</given-names></name><name><surname>Festoff</surname> <given-names>BW</given-names></name><name><surname>Gawel</surname> <given-names>MJ</given-names></name><name><surname>Gelinas</surname> <given-names>DF</given-names></name><name><surname>Kratz</surname> <given-names>R</given-names></name><name><surname>Murphy</surname> <given-names>MF</given-names></name><name><surname>Natter</surname> <given-names>HM</given-names></name><name><surname>Norris</surname> <given-names>FH</given-names></name><name><surname>Rudnicki</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Effect of recombinant human insulin-like growth factor-I on progression of ALS A placebo-controlled study the North America ALS/IGF-I study group</article-title><source>Neurology</source><volume>49</volume><fpage>1621</fpage><lpage>1630</lpage><pub-id pub-id-type="doi">10.1212/wnl.49.6.1621</pub-id><pub-id pub-id-type="pmid">9409357</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KH</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Mitrea</surname> <given-names>DM</given-names></name><name><surname>Sarkar</surname> <given-names>M</given-names></name><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Cika</surname> <given-names>J</given-names></name><name><surname>Coughlin</surname> <given-names>M</given-names></name><name><surname>Messing</surname> <given-names>J</given-names></name><name><surname>Molliex</surname> <given-names>A</given-names></name><name><surname>Maxwell</surname> <given-names>BA</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Temirov</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>J</given-names></name><name><surname>Kolaitis</surname> <given-names>RM</given-names></name><name><surname>Shaw</surname> <given-names>TI</given-names></name><name><surname>Bai</surname> <given-names>B</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Kriwacki</surname> <given-names>RW</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 dipeptide repeats impair the assembly, dynamics, and function of Membrane-Less organelles</article-title><source>Cell</source><volume>167</volume><fpage>774</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id><pub-id pub-id-type="pmid">27768896</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis</article-title><source>Neuron</source><volume>22</volume><fpage>451</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80701-1</pub-id><pub-id pub-id-type="pmid">10197526</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Handsaker</surname> <given-names>B</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Ruan</surname> <given-names>J</given-names></name><name><surname>Homer</surname> <given-names>N</given-names></name><name><surname>Marth</surname> <given-names>G</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The sequence alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Tran</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Poly(GR) in C9ORF72-Related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-Derived motor neurons</article-title><source>Neuron</source><volume>92</volume><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.015</pub-id><pub-id pub-id-type="pmid">27720481</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Pribadi</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>TS</given-names></name><name><surname>Krishnan</surname> <given-names>G</given-names></name><name><surname>Choi</surname> <given-names>SY</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in <italic>C9ORF72</italic>-ALS/FTD</article-title><source>PNAS</source><volume>116</volume><fpage>9628</fpage><lpage>9633</lpage><pub-id pub-id-type="doi">10.1073/pnas.1901313116</pub-id><pub-id pub-id-type="pmid">31019093</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariosa</surname> <given-names>D</given-names></name><name><surname>Kamel</surname> <given-names>F</given-names></name><name><surname>Bellocco</surname> <given-names>R</given-names></name><name><surname>Ye</surname> <given-names>W</given-names></name><name><surname>Fang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Association between diabetes and amyotrophic lateral sclerosis in Sweden</article-title><source>European Journal of Neurology</source><volume>22</volume><fpage>1436</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1111/ene.12632</pub-id><pub-id pub-id-type="pmid">25600257</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname> <given-names>JA</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Gucek</surname> <given-names>M</given-names></name><name><surname>Puertollano</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB</article-title><source>Autophagy</source><volume>8</volume><fpage>903</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.4161/auto.19653</pub-id><pub-id pub-id-type="pmid">22576015</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minard</surname> <given-names>AY</given-names></name><name><surname>Wong</surname> <given-names>MKL</given-names></name><name><surname>Chaudhuri</surname> <given-names>R</given-names></name><name><surname>Tan</surname> <given-names>S-X</given-names></name><name><surname>Humphrey</surname> <given-names>SJ</given-names></name><name><surname>Parker</surname> <given-names>BL</given-names></name><name><surname>Yang</surname> <given-names>JY</given-names></name><name><surname>Laybutt</surname> <given-names>DR</given-names></name><name><surname>Cooney</surname> <given-names>GJ</given-names></name><name><surname>Coster</surname> <given-names>ACF</given-names></name><name><surname>Stöckli</surname> <given-names>J</given-names></name><name><surname>James</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hyperactivation of the insulin signaling pathway improves intracellular proteostasis by coordinately Up-regulating the proteostatic machinery in adipocytes</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>25629</fpage><lpage>25640</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.741140</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname> <given-names>S</given-names></name><name><surname>Grönke</surname> <given-names>S</given-names></name><name><surname>Niccoli</surname> <given-names>T</given-names></name><name><surname>Ridler</surname> <given-names>CE</given-names></name><name><surname>Clayton</surname> <given-names>EL</given-names></name><name><surname>Devoy</surname> <given-names>A</given-names></name><name><surname>Moens</surname> <given-names>T</given-names></name><name><surname>Norona</surname> <given-names>FE</given-names></name><name><surname>Woollacott</surname> <given-names>IOC</given-names></name><name><surname>Pietrzyk</surname> <given-names>J</given-names></name><name><surname>Cleverley</surname> <given-names>K</given-names></name><name><surname>Nicoll</surname> <given-names>AJ</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Dols</surname> <given-names>J</given-names></name><name><surname>Cabecinha</surname> <given-names>M</given-names></name><name><surname>Hendrich</surname> <given-names>O</given-names></name><name><surname>Fratta</surname> <given-names>P</given-names></name><name><surname>Fisher</surname> <given-names>EMC</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9orf72 repeat expansions cause neurodegeneration in <italic>Drosophila</italic> through arginine-rich proteins</article-title><source>Science</source><volume>345</volume><fpage>1192</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1126/science.1256800</pub-id><pub-id pub-id-type="pmid">25103406</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname> <given-names>TG</given-names></name><name><surname>Mizielinska</surname> <given-names>S</given-names></name><name><surname>Niccoli</surname> <given-names>T</given-names></name><name><surname>Mitchell</surname> <given-names>JS</given-names></name><name><surname>Thoeng</surname> <given-names>A</given-names></name><name><surname>Ridler</surname> <given-names>CE</given-names></name><name><surname>Grönke</surname> <given-names>S</given-names></name><name><surname>Esser</surname> <given-names>J</given-names></name><name><surname>Heslegrave</surname> <given-names>A</given-names></name><name><surname>Zetterberg</surname> <given-names>H</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sense and antisense RNA are not toxic in <italic>Drosophila</italic> models of C9orf72-associated ALS/FTD</article-title><source>Acta Neuropathologica</source><volume>135</volume><fpage>445</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1007/s00401-017-1798-3</pub-id><pub-id pub-id-type="pmid">29380049</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname> <given-names>TG</given-names></name><name><surname>Niccoli</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>KM</given-names></name><name><surname>Atilano</surname> <given-names>ML</given-names></name><name><surname>Birsa</surname> <given-names>N</given-names></name><name><surname>Gittings</surname> <given-names>LM</given-names></name><name><surname>Holbling</surname> <given-names>BV</given-names></name><name><surname>Dyson</surname> <given-names>MC</given-names></name><name><surname>Thoeng</surname> <given-names>A</given-names></name><name><surname>Neeves</surname> <given-names>J</given-names></name><name><surname>Glaria</surname> <given-names>I</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Storkebaum</surname> <given-names>E</given-names></name><name><surname>Pardo</surname> <given-names>M</given-names></name><name><surname>Choudhary</surname> <given-names>JS</given-names></name><name><surname>Fratta</surname> <given-names>P</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A</article-title><source>Acta Neuropathologica</source><volume>137</volume><fpage>487</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1946-4</pub-id><pub-id pub-id-type="pmid">30604225</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>SM</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>van der Zee</surname> <given-names>J</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>881</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1189-3</pub-id><pub-id pub-id-type="pmid">24132570</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname> <given-names>I</given-names></name><name><surname>Shiote</surname> <given-names>M</given-names></name><name><surname>Murakami</surname> <given-names>T</given-names></name><name><surname>Kamada</surname> <given-names>H</given-names></name><name><surname>Hamakawa</surname> <given-names>Y</given-names></name><name><surname>Matsubara</surname> <given-names>E</given-names></name><name><surname>Yokoyama</surname> <given-names>M</given-names></name><name><surname>Moritaz</surname> <given-names>K</given-names></name><name><surname>Shoji</surname> <given-names>M</given-names></name><name><surname>Abe</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis</article-title><source>Neurological Research</source><volume>27</volume><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1179/016164105X39860</pub-id><pub-id pub-id-type="pmid">16197815</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narai</surname> <given-names>H</given-names></name><name><surname>Nagano</surname> <given-names>I</given-names></name><name><surname>Ilieva</surname> <given-names>H</given-names></name><name><surname>Shiote</surname> <given-names>M</given-names></name><name><surname>Nagata</surname> <given-names>T</given-names></name><name><surname>Hayashi</surname> <given-names>T</given-names></name><name><surname>Shoji</surname> <given-names>M</given-names></name><name><surname>Abe</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice</article-title><source>Journal of Neuroscience Research</source><volume>82</volume><fpage>452</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1002/jnr.20668</pub-id><pub-id pub-id-type="pmid">16235250</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname> <given-names>N</given-names></name><name><surname>Nishimori</surname> <given-names>Y</given-names></name><name><surname>Nishimura</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Conserved role for the dachshund protein with <italic>Drosophila</italic> Pax6 homolog eyeless in insulin expression</article-title><source>PNAS</source><volume>109</volume><fpage>2406</fpage><lpage>2411</lpage><pub-id pub-id-type="doi">10.1073/pnas.1116050109</pub-id><pub-id pub-id-type="pmid">22308399</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterwalder</surname> <given-names>T</given-names></name><name><surname>Yoon</surname> <given-names>KS</given-names></name><name><surname>White</surname> <given-names>BH</given-names></name><name><surname>Keshishian</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A conditional tissue-specific transgene expression system using inducible GAL4</article-title><source>PNAS</source><volume>98</volume><fpage>12596</fpage><lpage>12601</lpage><pub-id pub-id-type="doi">10.1073/pnas.221303298</pub-id><pub-id pub-id-type="pmid">11675495</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Wright</surname> <given-names>C</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Carter</surname> <given-names>K</given-names></name><name><surname>Bhatt</surname> <given-names>A</given-names></name><name><surname>Fan</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats</article-title><source>Neuroscience</source><volume>318</volume><fpage>157</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.01.020</pub-id><pub-id pub-id-type="pmid">26777890</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname> <given-names>K</given-names></name><name><surname>Sarkar</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tissue-Specific upregulation of <italic>Drosophila</italic> insulin receptor (InR) Mitigates poly(Q)-Mediated neurotoxicity by restoration of cellular transcription machinery</article-title><source>Molecular Neurobiology</source><volume>56</volume><fpage>1310</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1160-3</pub-id><pub-id pub-id-type="pmid">29881950</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname> <given-names>AE</given-names></name><name><surname>Majounie</surname> <given-names>E</given-names></name><name><surname>Waite</surname> <given-names>A</given-names></name><name><surname>Simón-Sánchez</surname> <given-names>J</given-names></name><name><surname>Rollinson</surname> <given-names>S</given-names></name><name><surname>Gibbs</surname> <given-names>JR</given-names></name><name><surname>Schymick</surname> <given-names>JC</given-names></name><name><surname>Laaksovirta</surname> <given-names>H</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name><name><surname>Myllykangas</surname> <given-names>L</given-names></name><name><surname>Kalimo</surname> <given-names>H</given-names></name><name><surname>Paetau</surname> <given-names>A</given-names></name><name><surname>Abramzon</surname> <given-names>Y</given-names></name><name><surname>Remes</surname> <given-names>AM</given-names></name><name><surname>Kaganovich</surname> <given-names>A</given-names></name><name><surname>Scholz</surname> <given-names>SW</given-names></name><name><surname>Duckworth</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Harmer</surname> <given-names>DW</given-names></name><name><surname>Hernandez</surname> <given-names>DG</given-names></name><name><surname>Johnson</surname> <given-names>JO</given-names></name><name><surname>Mok</surname> <given-names>K</given-names></name><name><surname>Ryten</surname> <given-names>M</given-names></name><name><surname>Trabzuni</surname> <given-names>D</given-names></name><name><surname>Guerreiro</surname> <given-names>RJ</given-names></name><name><surname>Orrell</surname> <given-names>RW</given-names></name><name><surname>Neal</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>J</given-names></name><name><surname>Jansen</surname> <given-names>IE</given-names></name><name><surname>Sondervan</surname> <given-names>D</given-names></name><name><surname>Seelaar</surname> <given-names>H</given-names></name><name><surname>Blake</surname> <given-names>D</given-names></name><name><surname>Young</surname> <given-names>K</given-names></name><name><surname>Halliwell</surname> <given-names>N</given-names></name><name><surname>Callister</surname> <given-names>JB</given-names></name><name><surname>Toulson</surname> <given-names>G</given-names></name><name><surname>Richardson</surname> <given-names>A</given-names></name><name><surname>Gerhard</surname> <given-names>A</given-names></name><name><surname>Snowden</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>D</given-names></name><name><surname>Neary</surname> <given-names>D</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Peuralinna</surname> <given-names>T</given-names></name><name><surname>Jansson</surname> <given-names>L</given-names></name><name><surname>Isoviita</surname> <given-names>VM</given-names></name><name><surname>Kaivorinne</surname> <given-names>AL</given-names></name><name><surname>Hölttä-Vuori</surname> <given-names>M</given-names></name><name><surname>Ikonen</surname> <given-names>E</given-names></name><name><surname>Sulkava</surname> <given-names>R</given-names></name><name><surname>Benatar</surname> <given-names>M</given-names></name><name><surname>Wuu</surname> <given-names>J</given-names></name><name><surname>Chiò</surname> <given-names>A</given-names></name><name><surname>Restagno</surname> <given-names>G</given-names></name><name><surname>Borghero</surname> <given-names>G</given-names></name><name><surname>Sabatelli</surname> <given-names>M</given-names></name><name><surname>Heckerman</surname> <given-names>D</given-names></name><name><surname>Rogaeva</surname> <given-names>E</given-names></name><name><surname>Zinman</surname> <given-names>L</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Sendtner</surname> <given-names>M</given-names></name><name><surname>Drepper</surname> <given-names>C</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Alkan</surname> <given-names>C</given-names></name><name><surname>Abdullaev</surname> <given-names>Z</given-names></name><name><surname>Pack</surname> <given-names>SD</given-names></name><name><surname>Dutra</surname> <given-names>A</given-names></name><name><surname>Pak</surname> <given-names>E</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Singleton</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>NM</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>HR</given-names></name><name><surname>Tienari</surname> <given-names>PJ</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><collab>ITALSGEN Consortium</collab></person-group><year iso-8601-date="2011">2011</year><article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title><source>Neuron</source><volume>72</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id><pub-id pub-id-type="pmid">21944779</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosivatz</surname> <given-names>E</given-names></name><name><surname>Matthews</surname> <given-names>JG</given-names></name><name><surname>McDonald</surname> <given-names>NQ</given-names></name><name><surname>Mulet</surname> <given-names>X</given-names></name><name><surname>Ho</surname> <given-names>KK</given-names></name><name><surname>Lossi</surname> <given-names>N</given-names></name><name><surname>Schmid</surname> <given-names>AC</given-names></name><name><surname>Mirabelli</surname> <given-names>M</given-names></name><name><surname>Pomeranz</surname> <given-names>KM</given-names></name><name><surname>Erneux</surname> <given-names>C</given-names></name><name><surname>Lam</surname> <given-names>EW</given-names></name><name><surname>Vilar</surname> <given-names>R</given-names></name><name><surname>Woscholski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)</article-title><source>ACS Chemical Biology</source><volume>1</volume><fpage>780</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1021/cb600352f</pub-id><pub-id pub-id-type="pmid">17240976</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonenberg</surname> <given-names>N</given-names></name><name><surname>Hinnebusch</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Regulation of translation initiation in eukaryotes: mechanisms and biological targets</article-title><source>Cell</source><volume>136</volume><fpage>731</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.01.042</pub-id><pub-id pub-id-type="pmid">19239892</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorenson</surname> <given-names>EJ</given-names></name><name><surname>Windbank</surname> <given-names>AJ</given-names></name><name><surname>Mandrekar</surname> <given-names>JN</given-names></name><name><surname>Bamlet</surname> <given-names>WR</given-names></name><name><surname>Appel</surname> <given-names>SH</given-names></name><name><surname>Armon</surname> <given-names>C</given-names></name><name><surname>Barkhaus</surname> <given-names>PE</given-names></name><name><surname>Bosch</surname> <given-names>P</given-names></name><name><surname>Boylan</surname> <given-names>K</given-names></name><name><surname>David</surname> <given-names>WS</given-names></name><name><surname>Feldman</surname> <given-names>E</given-names></name><name><surname>Glass</surname> <given-names>J</given-names></name><name><surname>Gutmann</surname> <given-names>L</given-names></name><name><surname>Katz</surname> <given-names>J</given-names></name><name><surname>King</surname> <given-names>W</given-names></name><name><surname>Luciano</surname> <given-names>CA</given-names></name><name><surname>McCluskey</surname> <given-names>LF</given-names></name><name><surname>Nash</surname> <given-names>S</given-names></name><name><surname>Newman</surname> <given-names>DS</given-names></name><name><surname>Pascuzzi</surname> <given-names>RM</given-names></name><name><surname>Pioro</surname> <given-names>E</given-names></name><name><surname>Sams</surname> <given-names>LJ</given-names></name><name><surname>Scelsa</surname> <given-names>S</given-names></name><name><surname>Simpson</surname> <given-names>EP</given-names></name><name><surname>Subramony</surname> <given-names>SH</given-names></name><name><surname>Tiryaki</surname> <given-names>E</given-names></name><name><surname>Thornton</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Subcutaneous IGF-1 is not beneficial in 2-year ALS trial</article-title><source>Neurology</source><volume>71</volume><fpage>1770</fpage><lpage>1775</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000335970.78664.36</pub-id><pub-id pub-id-type="pmid">19029516</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stopford</surname> <given-names>MJ</given-names></name><name><surname>Higginbottom</surname> <given-names>A</given-names></name><name><surname>Hautbergue</surname> <given-names>GM</given-names></name><name><surname>Cooper-Knock</surname> <given-names>J</given-names></name><name><surname>Mulcahy</surname> <given-names>PJ</given-names></name><name><surname>De Vos</surname> <given-names>KJ</given-names></name><name><surname>Renton</surname> <given-names>AE</given-names></name><name><surname>Pliner</surname> <given-names>H</given-names></name><name><surname>Calvo</surname> <given-names>A</given-names></name><name><surname>Chio</surname> <given-names>A</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><name><surname>Azzouz</surname> <given-names>M</given-names></name><name><surname>Heath</surname> <given-names>PR</given-names></name><name><surname>Kirby</surname> <given-names>J</given-names></name><name><surname>Shaw</surname> <given-names>PJ</given-names></name><collab>ITALSGEN Consortium, NeuroX Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of pten</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>1133</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx022</pub-id><pub-id pub-id-type="pmid">28158451</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracz</surname> <given-names>AF</given-names></name><name><surname>Szczylik</surname> <given-names>C</given-names></name><name><surname>Porta</surname> <given-names>C</given-names></name><name><surname>Czarnecka</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insulin-like growth factor-1 signaling in renal cell carcinoma</article-title><source>BMC Cancer</source><volume>16</volume><elocation-id>453</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-016-2437-4</pub-id><pub-id pub-id-type="pmid">27405474</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricoire</surname> <given-names>H</given-names></name><name><surname>Battisti</surname> <given-names>V</given-names></name><name><surname>Trannoy</surname> <given-names>S</given-names></name><name><surname>Lasbleiz</surname> <given-names>C</given-names></name><name><surname>Pret</surname> <given-names>AM</given-names></name><name><surname>Monnier</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The steroid hormone receptor EcR finely modulates <italic>Drosophila</italic> lifespan during adulthood in a sex-specific manner</article-title><source>Mechanisms of Ageing and Development</source><volume>130</volume><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2009.05.004</pub-id><pub-id pub-id-type="pmid">19486910</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Parra</surname> <given-names>JL</given-names></name><name><surname>Beugnet</surname> <given-names>A</given-names></name><name><surname>Proud</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>1546</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.5.1546-1557.2003</pub-id><pub-id pub-id-type="pmid">12588975</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Tan</surname> <given-names>W</given-names></name><name><surname>Westergard</surname> <given-names>T</given-names></name><name><surname>Krishnamurthy</surname> <given-names>K</given-names></name><name><surname>Markandaiah</surname> <given-names>SS</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Shneider</surname> <given-names>NA</given-names></name><name><surname>Monaghan</surname> <given-names>J</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Pasinelli</surname> <given-names>P</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name><name><surname>Trotti</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death</article-title><source>Neuron</source><volume>84</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id><pub-id pub-id-type="pmid">25521377</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wullschleger</surname> <given-names>S</given-names></name><name><surname>Loewith</surname> <given-names>R</given-names></name><name><surname>Hall</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TOR signaling in growth and metabolism</article-title><source>Cell</source><volume>124</volume><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.01.016</pub-id><pub-id pub-id-type="pmid">16469695</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>A</given-names></name><name><surname>Cremona</surname> <given-names>ML</given-names></name><name><surname>Rothman</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway</article-title><source>Journal of Cell Biology</source><volume>172</volume><fpage>719</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1083/jcb.200510065</pub-id><pub-id pub-id-type="pmid">16505167</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaia</surname> <given-names>A</given-names></name><name><surname>Piantanelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Alterations of brain insulin receptor characteristics in aging mice</article-title><source>Archives of Gerontology and Geriatrics</source><volume>23</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/0167-4943(96)00705-4</pub-id><pub-id pub-id-type="pmid">15374165</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Cunningham</surname> <given-names>KM</given-names></name><name><surname>Coyne</surname> <given-names>AN</given-names></name><name><surname>Ruan</surname> <given-names>K</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Bowen</surname> <given-names>KE</given-names></name><name><surname>Wadhwa</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Stress granule assembly disrupts nucleocytoplasmic transport</article-title><source>Cell</source><volume>173</volume><fpage>958</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.025</pub-id><pub-id pub-id-type="pmid">29628143</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Ebbert</surname> <given-names>MTW</given-names></name><name><surname>O'Raw</surname> <given-names>AD</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Cook</surname> <given-names>CN</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Pickles</surname> <given-names>SR</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Nature Medicine</source><volume>24</volume><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0071-1</pub-id><pub-id pub-id-type="pmid">29942091</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Gonzales</surname> <given-names>PK</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>O'Raw</surname> <given-names>AD</given-names></name><name><surname>Pickles</surname> <given-names>SR</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Carlomagno</surname> <given-names>Y</given-names></name><name><surname>Gachechiladze</surname> <given-names>MA</given-names></name><name><surname>Ludwig</surname> <given-names>C</given-names></name><name><surname>Tian</surname> <given-names>R</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Andersen</surname> <given-names>JW</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Datta</surname> <given-names>A</given-names></name><name><surname>Antognetti</surname> <given-names>G</given-names></name><name><surname>McCampbell</surname> <given-names>A</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Kampmann</surname> <given-names>M</given-names></name><name><surname>Ward</surname> <given-names>ME</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Link</surname> <given-names>CD</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heterochromatin anomalies and double-stranded RNA accumulation underlie <italic>C9orf72</italic> poly(PR) toxicity</article-title><source>Science</source><volume>363</volume><elocation-id>eaav2606</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav2606</pub-id><pub-id pub-id-type="pmid">30765536</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Pattamatta</surname> <given-names>A</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Repeat-Associated Non-ATG translation in neurological diseases</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a033019</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a033019</pub-id><pub-id pub-id-type="pmid">29891563</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58565.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Ramaswami</surname><given-names>Mani</given-names></name><role>Reviewing Editor</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ramaswami</surname><given-names>Mani</given-names> </name><role>Reviewer</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This work using appropriate <italic>Drosophila</italic> and mammalian cell models points to a novel therapeutic approach for C9ORF72 expansion-associated ALS/FTD patients. Key observations show that levels of insulin receptor ligands dilp2 and dilp3 are reduced in a <italic>Drosophila</italic> GGGGCC (G4C2) repeat expansion model and that activation of the insulin signaling mitigates multiple readouts of cytotoxicity. Together, the results suggest unusual conservation of insulin dependent neuroprotective mechanisms across species, which is of particular biological interest because <italic>Drosophila</italic> and mammalian insulin/ dilp secreting cells differ dramatically in anatomy and physiology.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in <italic>Drosophila</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Mani Ramaswami as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>The GGGGCC (G4C2) repeat expansion in c9orf72 is the most common genetic cause of both ALS and FTD. How expanded G4C2 repeats and their translation products such as poly(GR) induce neurodegeneration is incompletely understood. In this study, a transcriptomic analysis revealed reduced levels of mRNAs for the insulin receptor ligands dilp2 and dilp3 in flies expressing G4C2 repeats or poly(GR). Building on the observation, the authors show that activation of the insulin signaling mitigates multiple readouts of toxicity induced by poly(GR) or G4C2 repeats, possibly by decreasing poly(GR) level in these flies. Moreover, injection of insulin improved the survival of flies expressing G4C2 repeats. These findings based on studies in flies raise the possibility that the insulin signaling pathway is compromised in C9-ALS/FTD patients and that activation of this pathway may be a therapeutic approach for these disorders. If confirmed, these findings would be a timely contribution to this highly active field. However, several additional key controls and experiments are required to convincingly establish or clarify many of the above conclusions. In particular, a direct analysis of the survival of the dilp producing cells in their c9ORF model would be essential for the authors to determine whether they have discovered a cell type that shows adult degeneration in the model (which maybe valuable in itself but for reasons not addressed the current manuscript) or if the effect on insulin signalling may be a conserved feature in ALS as proposed.</p><p>Essential revisions:</p><p>There are two main lines of concern that need to be addressed before the manuscript can be accepted.</p><p>First, several controls for the genetic-interaction analyses are required to discriminate between the possibility that increased insulin signalling has a general effect on fly health or specifically improves survival and cytotoxicity in animals carrying (G4C2) repeat expansion.</p><p>Second, <italic>Drosophila</italic> and mammalian insulin/ dilp secreting cells appear completely different in anatomy and physiology. In <italic>Drosophila</italic> these cells grow very extensive and long neurites and could well be more sensitive to poly(GR) toxicity and their neurite development or even their survival could be greatly affected by elav-driven GR expression. Thus, the cellular basis for the observed dramatic decrease in insulin (Dilp2, 3) may well be quite unique to the fly model. In such a scenario, it would be difficult to extrapolate from these findings and propose a conserved pathogenic mechanism relevant to ALS patients.</p><p>1) In Figure 2, an important control is missing: the authors did not show whether activation of InR increases lifespan of control flies, such as the control (G4C2)3 flies described in an earlier report. (Not essential but interesting – considering the pro-survival effects of the insulin pathway, does InR(active) also decrease p53 level in fly models of other repeat-expansion diseases?)</p><p>2) A concern in Figure 3, as in Figure 2, is whether activation of insulin signaling promotes survival and cell proliferation in general. Thus, the effect in GR36 flies may not be specific. Indeed, expression of InR(active) or dilp2 in the wildtype eye seems to increase eye size as well; conversely, expression of InR(DN) in control flies decreases eye size (Figure 3B, C). Thus, one really cannot conclude that activation of insulin signaling &quot;reduces&quot; poly(GR) toxicity. Is this context p values for control flies should be stated as well. In particular, p values for comparisons between all genotypes in Panel B should be presented.</p><p>3) In Figure 5, the extent of increase in survival is so small and p value is barely &lt;0.05 with n=80, which is at the low end. To convincingly conclude that insulin injection &quot;rescues&quot; (G4C2)36 toxicity, this experiment should be repeated multiple times, and in each independent experiment, a lot more flies should be examined. Moreover, it seems to be essential to demonstrate a dosage-dependent effect.</p><p>4) In Figure 1, downregulation of dilps 2, 3, and 5 in GR100 flies should be confirmed by RT-PCR as done for (G4C2)36 flies. (the sentence &quot;in a model that expresses the pure repeats via RAN translation&quot; should be revised. It is unclear what &quot;pure repeats&quot; mean.)</p><p>5) In Figure 1, the authors should determine whether the insulin-producing cells in <italic>Drosophila</italic> are more susceptible to poly(GR) toxicity. Does overexpression of poly(GR) preferentially kill or alter distinctive and unusual <italic>Drosophila</italic> insulin-producing cells? This, could explain the rather dramatic downregulation of dilps 2, 3, and 5 in GR100 flies. We suggest that the issue could potentially be addressed using genetic tools described in (https://www.nature.com/articles/mp201651).</p><p>6) Whether downregulation of insulin is a genuine pathological event in C9 patients is a major outstanding question. Some direct arguments beyond what has been provided so far would be useful. Would a collaborative experiment to measure insulin levels in published C9 BAC transgenic mice be possible to include here?</p><p>7) In Figure 4, the results seem to be too preliminary and there is no indication of what the potential mechanism for reduced GR protein level could be. The authors should at least determine whether the poly(GR) mRNA level is affected. In the Introduction, the authors state that after activation of insulin signaling, &quot;translation initiation is increased, protein synthesis is up-regulated and autophagy is suppressed&quot;. This doesn't seem quite consistent with decreased poly(GR) level? Some more attention and explanation is needed here.</p><p>8) Using a canonically translated construct, polyGR 100X the authors find that InR CA reduces GR DPR levels, consistent with the notion that enhancing insulin signaling reduces the expression of toxic DPRs. Mechanistically, the authors place InR downstream of RAN translation based on the polyGR 100X result and the fact that InR CA mitigates G4C2 36X toxicity and also reduces polyGR generated via RAN translation. When considered in isolation, this interpretation seems reasonable however, given the authors' own conclusion that G4C2 36X levels are not changed by InR CA expression (Figure 2—figure supplement 3B) these data could also suggest that in fact increased insulin signaling inhibits RAN translation or affects the stability of poly GR produced by RAN translation.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58565.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>There are two main lines of concern that need to be addressed before the manuscript can be accepted.</p><p>First, several controls for the genetic-interaction analyses are required to discriminate between the possibility that increased insulin signalling has a general effect on fly health or specifically improves survival and cytotoxicity in animals carrying (G4C2) repeat expansion.</p></disp-quote><p>We agree with the reviewer that is important to ascertain if increased insulin signalling is beneficial as a general effect on fly health or if it specifically reduces toxicity of the (G4C2) repeat expansion. We have therefore overexpressed InR<sup>Active</sup> and InR<sup>DN</sup> in the neurons of wild-type flies and observed the opposite response, namely that increased insulin signalling significantly shortens lifespan of wild type flies. This is now included in the manuscript as Figure 2B. These new data indicate that increasing insulin signalling specifically supresses C9orf72 repeat toxicity for lifespan.</p><disp-quote content-type="editor-comment"><p>Second, <italic>Drosophila</italic> and mammalian insulin/ dilp secreting cells appear completely different in anatomy and physiology. In <italic>Drosophila</italic> these cells grow very extensive and long neurites and could well be more sensitive to poly(GR) toxicity and their neurite development or even their survival could be greatly affected by elav-driven GR expression. Thus, the cellular basis for the observed dramatic decrease in insulin (Dilp2, 3) may well be quite unique to the fly model. In such a scenario, it would be difficult to extrapolate from these findings and propose a conserved pathogenic mechanism relevant to ALS patients.</p></disp-quote><p>This is an important point, and we have now shown that neuronal expression of poly-GR using the Elav-GS driver does not alter IPC cell number or morphology in fly brains using dilp2 immunostaining, now added as Figure 1—figure supplement 3A-C. In addition, we specifically drove poly-GR in IPC cells using a dilp3 driver and again saw no cell death – now added as Figure 1—figure supplement 3D. These new data show that expression of poly-GR is not simply killing <italic>Drosophila</italic> IPCs, indicating that the mechanism of dilp reduction is due to detrimental effects of poly-GR that may also be relevant in other systems.</p><p>It is noteworthy that the amino acid sequence and structure of A and B chains of the <italic>Drosophila</italic> insulin peptides shows a high degree of conservation with the human insulin and human insulin-like growth factors (IGFs) (Broughton and Partridge, 2009; Sajid et al., 2011). Moreover, Insulin receptor (IR) and IGF-1 receptor share higher sequence homology, and both insulin and IGF-1 are able to bind to and activate each other’s receptors to elicit activation of downstream signalling pathways e.g. PI3K/AKT and Sc-Ras-Mapk (Taniguchi, Emanuelli and Kahn, 2006; Cai et al., 2017). Importantly, human insulin can bind and activate <italic>Drosophila</italic> InR (Yamaguchi, Fernandez and Roth, 1995; Vinayagam et al., 2016). In mammals, insulin and IGFs are subspecialized into systems with overlapping but distinct biological function, while in <italic>Drosophila</italic> there is a single insulin-like system that has the dual function of Insulin/IGF signalling. The pathogenic mechanism might therefore be related to IGFs rather than insulin. Importantly, the human brain produces IGF-1 and alteration of IGF-1 levels has been implicated in neurodegeneration (Bianchi, Locatelli and Rizzi, 2017). We therefore believe that our findings in <italic>Drosophila</italic> are relevant and might reveal a conserved pathogenic mechanism in ALS patients involving insulin/insulin-like growth factor (IIS). We have updated the Introduction and Discussion to highlight this.</p><disp-quote content-type="editor-comment"><p>1) In Figure 2, an important control is missing: the authors did not show whether activation of InR increases lifespan of control flies, such as the control (G4C2)3 flies described in an earlier report.</p></disp-quote><p>We have now addressed the reviewers concern with the new data in Figure 2B, which demonstrates that increased insulin signalling extends lifespan of the diseased flies while in healthy flies it shortens lifespan. This suggests that increasing insulin signalling specifically supresses C9orf72 repeat toxicity</p><disp-quote content-type="editor-comment"><p>(Not essential but interesting – considering the pro-survival effects of the insulin pathway, does InR(active) also decrease p53 level in fly models of other repeat-expansion diseases?)</p></disp-quote><p>We cannot find any evidence in the literature that this has been described in fly models of other repeat-expansion diseases.</p><disp-quote content-type="editor-comment"><p>2) A concern in Figure 3, as in Figure 2, is whether activation of insulin signaling promotes survival and cell proliferation in general. Thus, the effect in GR36 flies may not be specific. Indeed, expression of InR(active) or dilp2 in the wildtype eye seems to increase eye size as well; conversely, expression of InR(DN) in control flies decreases eye size (Figure 3B, C). Thus, one really cannot conclude that activation of insulin signaling &quot;reduces&quot; poly(GR) toxicity. Is this context p values for control flies should be stated as well. In particular, p values for comparisons between all genotypes in Panel B should be presented.</p></disp-quote><p>We appreciate the reviewer comment and indeed it is well established that insulin/IGF signalling during development promotes growth of the wild type eye (Brogiolo et al., 2001). However, we observe that the alterations in the eye are significantly stronger in GR36 flies expressing active or dominant negative InR than in control flies. This indicates a further additional effect specific to poly(GR) toxicity above the effect observed in wild type flies. For example, a dramatic decrease of eye size in GR36 flies is observed when insulin signalling is further reduced by expressing InR<sup>DN</sup>, while the rough eye phenotype is ameliorated in the presence of an active InR. Consistent with these observations, two-way Anova analysis showed a significant interaction between repeat expression and insulin signalling modulation, with a greater effect in flies expressing GR repeats than in the control flies. As suggested by the reviewer P values for the comparisons have been added to Figure 3 and figure legend, and we have highlighted this in the Results section of the manuscript.</p><disp-quote content-type="editor-comment"><p>3) In Figure 5, the extent of increase in survival is so small and p value is barely &lt;0.05 with n=80, which is at the low end. To convincingly conclude that insulin injection &quot;rescues&quot; (G4C2)36 toxicity, this experiment should be repeated multiple times, and in each independent experiment, a lot more flies should be examined. Moreover, it seems to be essential to demonstrate a dosage-dependent effect.</p></disp-quote><p>We have now shown that treatment with 0.03mg/ml of insulin increases survival of (G4C2)36 flies in three independent experiments – see Figure 6 and Figure 6—figure supplement 1A and B. The conclusions were consistent, with insulin significantly reducing lifespan of controls and increasing that of the disease model flies. We also administered a dose range of insulin (Figure 6—figure supplement 1A) which showed that 0.3mg/ml was not beneficial for survival of (G4C2)36 flies while 3mg/ml resulted in lethality.</p><disp-quote content-type="editor-comment"><p>4) In Figure 1, downregulation of dilps 2, 3, and 5 in GR100 flies should be confirmed by RT-PCR as done for (G4C2)36 flies. (the sentence &quot;in a model that expresses the pure repeats via RAN translation&quot; should be revised. It is unclear what &quot;pure repeats&quot; mean.)</p></disp-quote><p>We have performed the suggested RT-PCR experiment in GR100 flies and it showed that the transcript levels of dilp 2, 3, and 5 were significantly reduced, see Figure 1B.</p><disp-quote content-type="editor-comment"><p>5) In Figure 1, the authors should determine whether the insulin-producing cells in <italic>Drosophila</italic> are more susceptible to poly(GR) toxicity. Does overexpression of poly(GR) preferentially kill or alter distinctive and unusual <italic>Drosophila</italic> insulin-producing cells? This, could explain the rather dramatic downregulation of dilps 2, 3, and 5 in GR100 flies. We suggest that the issue could potentially be addressed using genetic tools described in (https://www.nature.com/articles/mp201651).</p></disp-quote><p>We have addressed this point by using some genetic tools and immunostaining described in (Monyak et al., 2017), as suggested by the reviewer. We used dilp-2 immunostaining to visualize the IPCs. We found that expression of poly-GR in the neurons using Elav-GS driver does not alter IPC cell number or morphology in the fly brains compared to control flies – Figure 1—figure supplement 3A and B. Additionally, we observed that specific expression of poly-GR repeats in IPCs using the dilp3-Gal4 driver does not induce cell death – see Figure 1—figure supplement 3D. These results, which are now included in the manuscript, argue convincingly against the idea that the reduced levels of <italic>dilps</italic> result from cell death of these neurons from poly-GR toxicity.</p><disp-quote content-type="editor-comment"><p>6) Whether downregulation of insulin is a genuine pathological event in C9 patients is a major outstanding question. Some direct arguments beyond what has been provided so far would be useful. Would a collaborative experiment to measure insulin levels in published C9 BAC transgenic mice be possible to include here?</p></disp-quote><p>We agree this is an important question. As in general the C9 BAC mice have only mild degenerative effects and it would be hard to interpret a negative result in those models. We therefore felt it was beyond the scope of the current manuscript to investigate this question in mice in a sufficiently meaningful manner.</p><p>However, given the importance of the question, we took a parallel approach and investigated whether insulin signalling affects DPR levels in mammalian cells. We used a reporter we have developed consisting of (GGGGCC)92 followed by nanoluciferase without an ATG start codon in the GR frame. Therefore, nanoluciferase signal is a direct read out of poly-GR levels. Using this reporter, we observed that, consistent with our results in <italic>Drosophila</italic>, activating the pathway decreases poly-GR levels while inhibiting insulin signalling increases poly-GR levels. These data are now included in the manuscript as Figure 5.</p><p>We also note that microarray data on laser capture microdissected motor neurons from C9orf72 patients showed that AKT signalling is altered (Stopford et al., 2017), which we now discuss in more detail in the Discussion.</p><disp-quote content-type="editor-comment"><p>7) In Figure 4, the results seem to be too preliminary and there is no indication of what the potential mechanism for reduced GR protein level could be. The authors should at least determine whether the poly(GR) mRNA level is affected. In the Introduction, the authors state that after activation of insulin signaling, &quot;translation initiation is increased, protein synthesis is up-regulated and autophagy is suppressed&quot;. This doesn't seem quite consistent with decreased poly(GR) level? Some more attention and explanation is needed here.</p></disp-quote><p>We have now measured the mRNA levels of the repeats in (G4C2)36 flies and (G4C2)36 flies expressing InR<sup>active</sup> and InR<sup>DN</sup> using dot blot hybridization analysis – Figure 2—figure supplement 1B. No significant differences were observed at transcriptional level between the genotypes. The change in poly-GR levels in (G4C2)36 flies expressing InR<sup>active</sup> must thus be attributable to a change in translation or degradation.</p><p>We understand the concerns of the reviewer regarding the fact that increased insulin signalling has been associated with reduced autophagy and this is potentially not consistent with decreased poly-GR levels. We have now mentioned in the Introduction and Discussion that insulin signalling pathway is a pro-survival pathway that has been associated with improved intracellular proteostasis (Minard et al., 2016) and this might play a role in poly-GR degradation.</p><disp-quote content-type="editor-comment"><p>8) Using a canonically translated construct, polyGR 100X the authors find that InR CA reduces GR DPR levels, consistent with the notion that enhancing insulin signaling reduces the expression of toxic DPRs. Mechanistically, the authors place InR downstream of RAN translation based on the polyGR 100X result and the fact that InR CA mitigates G4C2 36X toxicity and also reduces polyGR generated via RAN translation. When considered in isolation, this interpretation seems reasonable however, given the authors' own conclusion that G4C2 36X levels are not changed by InR CA expression (Figure 2—figure supplement 3B) these data could also suggest that in fact increased insulin signaling inhibits RAN translation or affects the stability of poly GR produced by RAN translation.</p></disp-quote><p>We agree with the reviewer that both are possible. We favour an effect downstream of RAN translation itself as in our GR model (ATG driven repeats – no RAN translation) we also observed a decrease of poly-GR. However, it is also possible that an additional effect on both RAN translation and poly-GR clearance/stability is contributing. In order to acknowledge this point, we have now added this possibility to the final sentence of the first paragraph of the Discussion.</p><p>References:</p><p>Bianchi VE, Locatelli V, Rizzi L (2017) Neurotrophic and Neuroregenerative Effects of GH/IGF1. International journal of molecular sciences 18.Cai W, Sakaguchi M, Kleinridders A, Gonzalez-Del Pino G, Dreyfuss JM, O'Neill BT, Ramirez AK, Pan H, Winnay JN, Boucher J, Eck MJ, Kahn CR (2017) Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nature communications 8:14892.Monyak RE, Emerson D, Schoenfeld BP, Zheng X, Chambers DB, Rosenfelt C, Langer S, Hinchey P, Choi CH, McDonald TV, Bolduc FV, Sehgal A, McBride SMJ, Jongens TA (2017) Insulin signaling misregulation underlies circadian and cognitive deficits in a <italic>Drosophila</italic> fragile X model. Molecular psychiatry 22:1140-1148.Sajid W, Kulahin N, Schluckebier G, Ribel U, Henderson HR, Tatar M, Hansen BF, Svendsen AM, Kiselyov VV, Norgaard P, Wahlund PO, Brandt J, Kohanski RA, Andersen AS, De Meyts P (2011) Structural and biological properties of the <italic>Drosophila</italic> insulin-like peptide 5 show evolutionary conservation. The Journal of biological chemistry 286:661-673.Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nature reviews Molecular cell biology 7:85-96.Vinayagam A, Kulkarni MM, Sopko R, Sun X, Hu Y, Nand A, Villalta C, Moghimi A, Yang X, Mohr SE, Hong P, Asara JM, Perrimon N (2016) An Integrative Analysis of the InR/PI3K/Akt Network Identifies the Dynamic Response to Insulin Signaling. Cell reports 16:3062-3074.Yamaguchi T, Fernandez R, Roth RA (1995) Comparison of the signaling abilities of the <italic>Drosophila</italic> and human insulin receptors in mammalian cells. Biochemistry 34:4962-4968.</p></body></sub-article></article>